{"taxa": [{"scientific_name": "bupleurum chinense dc", "compounds": ["saikosaponin b4", "(-)-yatein", "fatty acids", "3\u03b2,16\u03b2,23,28-tetrahydroxy-11\u03b1-methoxy-olean-12-ene3-o-\u03b2-d-fucopyranoside", "23-hydroxy-13\u03b2, 28\u03b2-epoxy-olean-11-ene-16-one3-o-\u03b2-d-glucopyranosyl-(1\u21923)-\u03b2-d-fucopyranoside", "3\u03b2,16\u03b2,28-trihydroxyl-11\u03b1-methoxy-olean-12-ene-o-\u03b2-d-fucopyranoside", "pentadecanoic acid", "11-hexadecenoic acid", "isokaerophyllin", "isochaihulactone", "saikosaponin b2", "saikosaponin b1", "triterpenoid saponins", "3\u03b2,16\u03b2-dihydroxy-23-o-acetyl-13\u03b2, 28\u03b2-epoxy-olean-11-ene3-o-\u03b2-d-fucopyranoside", "saikosaponin b3", "bupleuroside x", "sterols", "6''-o-acetylsaikosaponin d", "butanedioic acid", "narcissin", "saikosaponin c", "flavonoids", "kaerophyllin", "palmitoleic acid", "saikosaponin i", "prosaikogenin d", "7,4'-dihydroxy-isoflavone-7-o-\u03b2-d-glucoside", "bupleuroside xii", "2''-o-acetylsaikosaponin a", "(2z,8z,10e)-heptadecatriene-4,6-diyne-1-ol", "essential oils", "fumaric acid", "bupleuroside i", "nortrachelogenin", "saikosaponin e", "saikosaponin d", "\u03b1-spinasterol", "24\u03be-methylcholesta-7, 22e-diene-3\u03b2,5\u03b1,6\u03b2-triol", "3\u03b2,23,28-trihydroxy-11, 13(18)-diene-16-one3-o-\u03b2-d-glucopyranosyl-(1\u21923)-\u03b2-d-fucopyranoside", "isorhamnetin", "stearic acid", "linoleic acid", "prosaikogenin f", "bupleurynol", "nemerosin", "rutin", "puerarin", "saikochrome a", "23-o-acetylsaikosaponin a", "prosaikogenin a", "chinensinaphthol", "(2z,8e,10e)-pentadecatriene-4,6-diyne-1-ol", "polyacetylenes", "saikosaponin g", "lignans", "saikochromic acid", "13-octadecenoic acid", "prosaikogenin g", "saikosaponin f", "saikoisoflavonoside a", "bupleuroside v", "saikosaponin a", "saikochromoside a", "palmitic acid", "eugenin", "bupleuroside xi", "(2z,8z,10e)-pentadecatriene-4,6-diyne-1-ol", "9s,12s,13s-trihydroxy-10e-octadecenoic acid", "saikosaponin v-1", "chaihunaphthone", "bupleuroside vii", "6''-o-acetylsaikosaponin a", "oleic acid", "bupleuroside viii", "saikosaponin h", "quercetin", "tetracosanoic acid", "24\u03be-ethylcholest-22e-end-3\u03b2,5\u03b1,6\u03b2-triol", "6''-o-acetyl-saikosaponin b2", "3''-o-acetylsaikosaponin a", "isorhamnetin-3-o-glucoside"], "accepted_name": "Bupleurum chinense", "accepted_species": "Bupleurum chinense", "accepted_genus": "Bupleurum", "inchi_keys": {"saikosaponin b4": "GLQYFMRUYWFXGT-TZWHAUNMSA-N", "(-)-yatein": "GMLDZDDTZKXJLU-JKSUJKDBSA-N", "pentadecanoic acid": "WQEPLUUGTLDZJY-UHFFFAOYSA-N", "11-hexadecenoic acid": "JGMYDQCXGIMHLL-AATRIKPKSA-N", "isochaihulactone": "CJLVKDPRUXBTJQ-BESIOYJRSA-N", "saikosaponin b2": "WRYJYFCCMSVEPQ-ORAXXRKOSA-N", "saikosaponin b1": "WRYJYFCCMSVEPQ-MNIDVGFKSA-N", "saikosaponin b3": "GLQYFMRUYWFXGT-ZGFARVGISA-N", "bupleuroside x": "XLJYDQXNCUSNDG-XSCWCESOSA-N", "sterols": "FPXSXMFOYWRHDX-UHFFFAOYSA-N", "6''-o-acetylsaikosaponin d": "WDWZBAMDKXKRBA-YBZZVAQVSA-N", "butanedioic acid": "KDYFGRWQOYBRFD-UHFFFAOYSA-N", "narcissin": "UIDGLYUNOUKLBM-GEBJFKNCSA-N", "saikosaponin c": "VJEMOEYSQDKAQF-JDRYWMLESA-N", "kaerophyllin": "CSKOHFAJPKLSBP-MDNIKOHYSA-N", "palmitoleic acid": "SECPZKHBENQXJG-FPLPWBNLSA-N", "saikosaponin i": "CMCKJNVAUXCQCZ-UHFFFAOYSA-N", "prosaikogenin d": "UAUUFLADFXKYAU-WQPKRVEVSA-N", "bupleuroside xii": "ADBAOQFRJFTJSD-SAGKUDLOSA-N", "2''-o-acetylsaikosaponin a": "SRKDRDBFLMDBPW-UHFFFAOYSA-N", "(2z,8z,10e)-heptadecatriene-4,6-diyne-1-ol": "ZPLZIXYVLVONAD-ZXJJOWAZSA-N", "fumaric acid": "VZCYOOQTPOCHFL-OWOJBTEDSA-N", "bupleuroside i": "NXWBRHQQKIQDCN-UXKPDXCRSA-N", "nortrachelogenin": "ZITBJWXLODLDRH-XOBRGWDASA-N", "saikosaponin e": "KQGDHYQRJRGMDG-CYMACDCKSA-N", "saikosaponin d": "KYWSCMDFVARMPN-LCSVLAELSA-N", "\u03b1-spinasterol": "JZVFJDZBLUFKCA-FXIAWGAOSA-N", "isorhamnetin": "IZQSVPBOUDKVDZ-UHFFFAOYSA-N", "stearic acid": "QIQXTHQIDYTFRH-UHFFFAOYSA-N", "linoleic acid": "OYHQOLUKZRVURQ-HZJYTTRNSA-N", "prosaikogenin f": "WSSVJIGMYVWUJL-WMYDXDAXSA-N", "bupleurynol": "NSVMMMROPMMCOH-LLBVTOMBSA-N", "nemerosin": "CJLVKDPRUXBTJQ-APSNUPSMSA-N", "rutin": "IKGXIBQEEMLURG-NVPNHPEKSA-N", "puerarin": "HKEAFJYKMMKDOR-VPRICQMDSA-N", "prosaikogenin a": "UAUUFLADFXKYAU-AKICHWIXSA-N", "chinensinaphthol": "ZYUVOQCJYNAWNV-UHFFFAOYSA-N", "(2z,8e,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG-GXZMIRGCSA-N", "saikosaponin g": "UFEGAVYKHITZAC-RUCQNWDKSA-N", "lignans": "YJGVMLPVUAXIQN-BCVBHCCTSA-N", "13-octadecenoic acid": "BDLLSHRIFPDGQB-AATRIKPKSA-N", "prosaikogenin g": "WSSVJIGMYVWUJL-LRSKSROMSA-N", "saikosaponin f": "SXILFEBNQCRWAL-VERCZQKXSA-N", "bupleuroside v": "ZZPLELRHPJGMIH-HOMGMXHNSA-N", "saikosaponin a": "KYWSCMDFVARMPN-MSSMMRRTSA-N", "saikochromoside a": "UIKLIOIWCUSJML-USACIQFYSA-N", "palmitic acid": "IPCSVZSSVZVIGE-UHFFFAOYSA-N", "eugenin": "SUTUBQHKZRNZRA-UHFFFAOYSA-N", "bupleuroside xi": "CJNJNXRLVVGTQW-GUIWJIGYSA-N", "(2z,8z,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG-KQKHETANSA-N", "9s,12s,13s-trihydroxy-10e-octadecenoic acid": "MDIUMSLCYIJBQC-MVFSOIOZSA-N", "chaihunaphthone": "GVORHOLLLQETHK-UHFFFAOYSA-N", "bupleuroside vii": "RJNRPQJOFWBQJN-PWMVBUCLSA-N", "6''-o-acetylsaikosaponin a": "WDWZBAMDKXKRBA-HCYXLWPCSA-N", "oleic acid": "ZQPPMHVWECSIRJ-KTKRTIGZSA-N", "saikosaponin h": "PYJMYPPFWASOJX-XMRFJGCSSA-N", "quercetin": "REFJWTPEDVJJIY-UHFFFAOYSA-N", "tetracosanoic acid": "QZZGJDVWLFXDLK-UHFFFAOYSA-N", "6''-o-acetyl-saikosaponin b2": "JVVGHTDCSIJQTI-IVKXVHIYSA-N", "isorhamnetin-3-o-glucoside": "CQLRUIIRRZYHHS-LFXZADKFSA-N"}, "inchi_key_simps": {"saikosaponin b4": "GLQYFMRUYWFXGT", "(-)-yatein": "GMLDZDDTZKXJLU", "pentadecanoic acid": "WQEPLUUGTLDZJY", "11-hexadecenoic acid": "JGMYDQCXGIMHLL", "isochaihulactone": "CJLVKDPRUXBTJQ", "saikosaponin b2": "WRYJYFCCMSVEPQ", "saikosaponin b1": "WRYJYFCCMSVEPQ", "saikosaponin b3": "GLQYFMRUYWFXGT", "bupleuroside x": "XLJYDQXNCUSNDG", "sterols": "FPXSXMFOYWRHDX", "6''-o-acetylsaikosaponin d": "WDWZBAMDKXKRBA", "butanedioic acid": "KDYFGRWQOYBRFD", "narcissin": "UIDGLYUNOUKLBM", "saikosaponin c": "VJEMOEYSQDKAQF", "kaerophyllin": "CSKOHFAJPKLSBP", "palmitoleic acid": "SECPZKHBENQXJG", "saikosaponin i": "CMCKJNVAUXCQCZ", "prosaikogenin d": "UAUUFLADFXKYAU", "bupleuroside xii": "ADBAOQFRJFTJSD", "2''-o-acetylsaikosaponin a": "SRKDRDBFLMDBPW", "(2z,8z,10e)-heptadecatriene-4,6-diyne-1-ol": "ZPLZIXYVLVONAD", "fumaric acid": "VZCYOOQTPOCHFL", "bupleuroside i": "NXWBRHQQKIQDCN", "nortrachelogenin": "ZITBJWXLODLDRH", "saikosaponin e": "KQGDHYQRJRGMDG", "saikosaponin d": "KYWSCMDFVARMPN", "\u03b1-spinasterol": "JZVFJDZBLUFKCA", "isorhamnetin": "IZQSVPBOUDKVDZ", "stearic acid": "QIQXTHQIDYTFRH", "linoleic acid": "OYHQOLUKZRVURQ", "prosaikogenin f": "WSSVJIGMYVWUJL", "bupleurynol": "NSVMMMROPMMCOH", "nemerosin": "CJLVKDPRUXBTJQ", "rutin": "IKGXIBQEEMLURG", "puerarin": "HKEAFJYKMMKDOR", "prosaikogenin a": "UAUUFLADFXKYAU", "chinensinaphthol": "ZYUVOQCJYNAWNV", "(2z,8e,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG", "saikosaponin g": "UFEGAVYKHITZAC", "lignans": "YJGVMLPVUAXIQN", "13-octadecenoic acid": "BDLLSHRIFPDGQB", "prosaikogenin g": "WSSVJIGMYVWUJL", "saikosaponin f": "SXILFEBNQCRWAL", "bupleuroside v": "ZZPLELRHPJGMIH", "saikosaponin a": "KYWSCMDFVARMPN", "saikochromoside a": "UIKLIOIWCUSJML", "palmitic acid": "IPCSVZSSVZVIGE", "eugenin": "SUTUBQHKZRNZRA", "bupleuroside xi": "CJNJNXRLVVGTQW", "(2z,8z,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG", "9s,12s,13s-trihydroxy-10e-octadecenoic acid": "MDIUMSLCYIJBQC", "chaihunaphthone": "GVORHOLLLQETHK", "bupleuroside vii": "RJNRPQJOFWBQJN", "6''-o-acetylsaikosaponin a": "WDWZBAMDKXKRBA", "oleic acid": "ZQPPMHVWECSIRJ", "saikosaponin h": "PYJMYPPFWASOJX", "quercetin": "REFJWTPEDVJJIY", "tetracosanoic acid": "QZZGJDVWLFXDLK", "6''-o-acetyl-saikosaponin b2": "JVVGHTDCSIJQTI", "isorhamnetin-3-o-glucoside": "CQLRUIIRRZYHHS"}}, {"scientific_name": "bupleurum scorzonerifolium willd", "compounds": ["saikosaponin b4", "(-)-yatein", "fatty acids", "3\u03b2,16\u03b2,23,28-tetrahydroxy-11\u03b1-methoxy-olean-12-ene3-o-\u03b2-d-fucopyranoside", "23-hydroxy-13\u03b2, 28\u03b2-epoxy-olean-11-ene-16-one3-o-\u03b2-d-glucopyranosyl-(1\u21923)-\u03b2-d-fucopyranoside", "3\u03b2,16\u03b2,28-trihydroxyl-11\u03b1-methoxy-olean-12-ene-o-\u03b2-d-fucopyranoside", "pentadecanoic acid", "11-hexadecenoic acid", "isokaerophyllin", "isochaihulactone", "saikosaponin b2", "saikosaponin b1", "triterpenoid saponins", "3\u03b2,16\u03b2-dihydroxy-23-o-acetyl-13\u03b2, 28\u03b2-epoxy-olean-11-ene3-o-\u03b2-d-fucopyranoside", "saikosaponin b3", "bupleuroside x", "sterols", "6''-o-acetylsaikosaponin d", "butanedioic acid", "narcissin", "saikosaponin c", "flavonoids", "kaerophyllin", "palmitoleic acid", "saikosaponin i", "prosaikogenin d", "7,4'-dihydroxy-isoflavone-7-o-\u03b2-d-glucoside", "bupleuroside xii", "2''-o-acetylsaikosaponin a", "(2z,8z,10e)-heptadecatriene-4,6-diyne-1-ol", "essential oils", "fumaric acid", "bupleuroside i", "nortrachelogenin", "saikosaponin e", "saikosaponin d", "\u03b1-spinasterol", "24\u03be-methylcholesta-7, 22e-diene-3\u03b2,5\u03b1,6\u03b2-triol", "3\u03b2,23,28-trihydroxy-11, 13(18)-diene-16-one3-o-\u03b2-d-glucopyranosyl-(1\u21923)-\u03b2-d-fucopyranoside", "isorhamnetin", "stearic acid", "linoleic acid", "prosaikogenin f", "bupleurynol", "nemerosin", "rutin", "puerarin", "saikochrome a", "23-o-acetylsaikosaponin a", "prosaikogenin a", "chinensinaphthol", "(2z,8e,10e)-pentadecatriene-4,6-diyne-1-ol", "polyacetylenes", "saikosaponin g", "lignans", "saikochromic acid", "13-octadecenoic acid", "prosaikogenin g", "saikosaponin f", "saikoisoflavonoside a", "bupleuroside v", "saikosaponin a", "saikochromoside a", "palmitic acid", "eugenin", "bupleuroside xi", "(2z,8z,10e)-pentadecatriene-4,6-diyne-1-ol", "9s,12s,13s-trihydroxy-10e-octadecenoic acid", "saikosaponin v-1", "chaihunaphthone", "bupleuroside vii", "6''-o-acetylsaikosaponin a", "oleic acid", "bupleuroside viii", "saikosaponin h", "quercetin", "tetracosanoic acid", "24\u03be-ethylcholest-22e-end-3\u03b2,5\u03b1,6\u03b2-triol", "6''-o-acetyl-saikosaponin b2", "3''-o-acetylsaikosaponin a", "isorhamnetin-3-o-glucoside"], "accepted_name": "Bupleurum scorzonerifolium", "accepted_species": "Bupleurum scorzonerifolium", "accepted_genus": "Bupleurum", "inchi_keys": {"saikosaponin b4": "GLQYFMRUYWFXGT-TZWHAUNMSA-N", "(-)-yatein": "GMLDZDDTZKXJLU-JKSUJKDBSA-N", "pentadecanoic acid": "WQEPLUUGTLDZJY-UHFFFAOYSA-N", "11-hexadecenoic acid": "JGMYDQCXGIMHLL-AATRIKPKSA-N", "isochaihulactone": "CJLVKDPRUXBTJQ-BESIOYJRSA-N", "saikosaponin b2": "WRYJYFCCMSVEPQ-ORAXXRKOSA-N", "saikosaponin b1": "WRYJYFCCMSVEPQ-MNIDVGFKSA-N", "saikosaponin b3": "GLQYFMRUYWFXGT-ZGFARVGISA-N", "bupleuroside x": "XLJYDQXNCUSNDG-XSCWCESOSA-N", "sterols": "FPXSXMFOYWRHDX-UHFFFAOYSA-N", "6''-o-acetylsaikosaponin d": "WDWZBAMDKXKRBA-YBZZVAQVSA-N", "butanedioic acid": "KDYFGRWQOYBRFD-UHFFFAOYSA-N", "narcissin": "UIDGLYUNOUKLBM-GEBJFKNCSA-N", "saikosaponin c": "VJEMOEYSQDKAQF-JDRYWMLESA-N", "kaerophyllin": "CSKOHFAJPKLSBP-MDNIKOHYSA-N", "palmitoleic acid": "SECPZKHBENQXJG-FPLPWBNLSA-N", "saikosaponin i": "CMCKJNVAUXCQCZ-UHFFFAOYSA-N", "prosaikogenin d": "UAUUFLADFXKYAU-WQPKRVEVSA-N", "bupleuroside xii": "ADBAOQFRJFTJSD-SAGKUDLOSA-N", "2''-o-acetylsaikosaponin a": "SRKDRDBFLMDBPW-UHFFFAOYSA-N", "(2z,8z,10e)-heptadecatriene-4,6-diyne-1-ol": "ZPLZIXYVLVONAD-ZXJJOWAZSA-N", "fumaric acid": "VZCYOOQTPOCHFL-OWOJBTEDSA-N", "bupleuroside i": "NXWBRHQQKIQDCN-UXKPDXCRSA-N", "nortrachelogenin": "ZITBJWXLODLDRH-XOBRGWDASA-N", "saikosaponin e": "KQGDHYQRJRGMDG-CYMACDCKSA-N", "saikosaponin d": "KYWSCMDFVARMPN-LCSVLAELSA-N", "\u03b1-spinasterol": "JZVFJDZBLUFKCA-FXIAWGAOSA-N", "isorhamnetin": "IZQSVPBOUDKVDZ-UHFFFAOYSA-N", "stearic acid": "QIQXTHQIDYTFRH-UHFFFAOYSA-N", "linoleic acid": "OYHQOLUKZRVURQ-HZJYTTRNSA-N", "prosaikogenin f": "WSSVJIGMYVWUJL-WMYDXDAXSA-N", "bupleurynol": "NSVMMMROPMMCOH-LLBVTOMBSA-N", "nemerosin": "CJLVKDPRUXBTJQ-APSNUPSMSA-N", "rutin": "IKGXIBQEEMLURG-NVPNHPEKSA-N", "puerarin": "HKEAFJYKMMKDOR-VPRICQMDSA-N", "prosaikogenin a": "UAUUFLADFXKYAU-AKICHWIXSA-N", "chinensinaphthol": "ZYUVOQCJYNAWNV-UHFFFAOYSA-N", "(2z,8e,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG-GXZMIRGCSA-N", "saikosaponin g": "UFEGAVYKHITZAC-RUCQNWDKSA-N", "lignans": "YJGVMLPVUAXIQN-BCVBHCCTSA-N", "13-octadecenoic acid": "BDLLSHRIFPDGQB-AATRIKPKSA-N", "prosaikogenin g": "WSSVJIGMYVWUJL-LRSKSROMSA-N", "saikosaponin f": "SXILFEBNQCRWAL-VERCZQKXSA-N", "bupleuroside v": "ZZPLELRHPJGMIH-HOMGMXHNSA-N", "saikosaponin a": "KYWSCMDFVARMPN-MSSMMRRTSA-N", "saikochromoside a": "UIKLIOIWCUSJML-USACIQFYSA-N", "palmitic acid": "IPCSVZSSVZVIGE-UHFFFAOYSA-N", "eugenin": "SUTUBQHKZRNZRA-UHFFFAOYSA-N", "bupleuroside xi": "CJNJNXRLVVGTQW-GUIWJIGYSA-N", "(2z,8z,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG-KQKHETANSA-N", "9s,12s,13s-trihydroxy-10e-octadecenoic acid": "MDIUMSLCYIJBQC-MVFSOIOZSA-N", "chaihunaphthone": "GVORHOLLLQETHK-UHFFFAOYSA-N", "bupleuroside vii": "RJNRPQJOFWBQJN-PWMVBUCLSA-N", "6''-o-acetylsaikosaponin a": "WDWZBAMDKXKRBA-HCYXLWPCSA-N", "oleic acid": "ZQPPMHVWECSIRJ-KTKRTIGZSA-N", "saikosaponin h": "PYJMYPPFWASOJX-XMRFJGCSSA-N", "quercetin": "REFJWTPEDVJJIY-UHFFFAOYSA-N", "tetracosanoic acid": "QZZGJDVWLFXDLK-UHFFFAOYSA-N", "6''-o-acetyl-saikosaponin b2": "JVVGHTDCSIJQTI-IVKXVHIYSA-N", "isorhamnetin-3-o-glucoside": "CQLRUIIRRZYHHS-LFXZADKFSA-N"}, "inchi_key_simps": {"saikosaponin b4": "GLQYFMRUYWFXGT", "(-)-yatein": "GMLDZDDTZKXJLU", "pentadecanoic acid": "WQEPLUUGTLDZJY", "11-hexadecenoic acid": "JGMYDQCXGIMHLL", "isochaihulactone": "CJLVKDPRUXBTJQ", "saikosaponin b2": "WRYJYFCCMSVEPQ", "saikosaponin b1": "WRYJYFCCMSVEPQ", "saikosaponin b3": "GLQYFMRUYWFXGT", "bupleuroside x": "XLJYDQXNCUSNDG", "sterols": "FPXSXMFOYWRHDX", "6''-o-acetylsaikosaponin d": "WDWZBAMDKXKRBA", "butanedioic acid": "KDYFGRWQOYBRFD", "narcissin": "UIDGLYUNOUKLBM", "saikosaponin c": "VJEMOEYSQDKAQF", "kaerophyllin": "CSKOHFAJPKLSBP", "palmitoleic acid": "SECPZKHBENQXJG", "saikosaponin i": "CMCKJNVAUXCQCZ", "prosaikogenin d": "UAUUFLADFXKYAU", "bupleuroside xii": "ADBAOQFRJFTJSD", "2''-o-acetylsaikosaponin a": "SRKDRDBFLMDBPW", "(2z,8z,10e)-heptadecatriene-4,6-diyne-1-ol": "ZPLZIXYVLVONAD", "fumaric acid": "VZCYOOQTPOCHFL", "bupleuroside i": "NXWBRHQQKIQDCN", "nortrachelogenin": "ZITBJWXLODLDRH", "saikosaponin e": "KQGDHYQRJRGMDG", "saikosaponin d": "KYWSCMDFVARMPN", "\u03b1-spinasterol": "JZVFJDZBLUFKCA", "isorhamnetin": "IZQSVPBOUDKVDZ", "stearic acid": "QIQXTHQIDYTFRH", "linoleic acid": "OYHQOLUKZRVURQ", "prosaikogenin f": "WSSVJIGMYVWUJL", "bupleurynol": "NSVMMMROPMMCOH", "nemerosin": "CJLVKDPRUXBTJQ", "rutin": "IKGXIBQEEMLURG", "puerarin": "HKEAFJYKMMKDOR", "prosaikogenin a": "UAUUFLADFXKYAU", "chinensinaphthol": "ZYUVOQCJYNAWNV", "(2z,8e,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG", "saikosaponin g": "UFEGAVYKHITZAC", "lignans": "YJGVMLPVUAXIQN", "13-octadecenoic acid": "BDLLSHRIFPDGQB", "prosaikogenin g": "WSSVJIGMYVWUJL", "saikosaponin f": "SXILFEBNQCRWAL", "bupleuroside v": "ZZPLELRHPJGMIH", "saikosaponin a": "KYWSCMDFVARMPN", "saikochromoside a": "UIKLIOIWCUSJML", "palmitic acid": "IPCSVZSSVZVIGE", "eugenin": "SUTUBQHKZRNZRA", "bupleuroside xi": "CJNJNXRLVVGTQW", "(2z,8z,10e)-pentadecatriene-4,6-diyne-1-ol": "AKLBACKPNSVAIG", "9s,12s,13s-trihydroxy-10e-octadecenoic acid": "MDIUMSLCYIJBQC", "chaihunaphthone": "GVORHOLLLQETHK", "bupleuroside vii": "RJNRPQJOFWBQJN", "6''-o-acetylsaikosaponin a": "WDWZBAMDKXKRBA", "oleic acid": "ZQPPMHVWECSIRJ", "saikosaponin h": "PYJMYPPFWASOJX", "quercetin": "REFJWTPEDVJJIY", "tetracosanoic acid": "QZZGJDVWLFXDLK", "6''-o-acetyl-saikosaponin b2": "JVVGHTDCSIJQTI", "isorhamnetin-3-o-glucoside": "CQLRUIIRRZYHHS"}}], "text": "Review ArticleRadix Bupleuri: A Review of Traditional Uses, Botany,Phytochemistry, Pharmacology, and ToxicologyFude Yang,1 Xiaoxv Dong,2 Xingbin Yin,2 WenpingWang,2 Longtai You,2 and Jian Ni1,21Gansu University of Chinese Medicine, Lanzhou 730000, China2School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, ChinaCorrespondence should be addressed to Jian Ni; njtcm@263.netReceived 14 February 2017; Accepted 20 April 2017; Published 16 May 2017Academic Editor: Gail B. MahadyCopyright \u00a9 2017 Fude Yang et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Radix Bupleuri (Chaihu) has been used as a traditional medicine for more than 2000 years in China, Japan, Korea, and otherAsian countries. Phytochemical studies demonstrated that this plant contains essential oils, triterpenoid saponins, polyacetylenes,flavonoids, lignans, fatty acids, and sterols. Crude extracts and pure compounds isolated from Radix Bupleuri exhibited variousbiological activities, such as anti-inflammatory, anticancer, antipyretic, antimicrobial, antiviral, hepatoprotective, neuroprotective,and immunomodulatory effects. However, Radix Bupleuri could also lead to hepatotoxicity, particularly in high doses and withlong-termuse. Pharmacokinetic studies have demonstrated that themajor bioactive compounds (saikosaponins a, b2, c, and d) wereabsorbed rapidly in rats after oral administration of the extract of Radix Bupleuri. This review aims to comprehensively summarizethe traditional uses, botany, phytochemistry, pharmacology, toxicology, and pharmacokinetics of Radix Bupleuri reported to datewith an emphasis on its biological properties and mechanisms of action.1. IntroductionRadix Bupleuri, also called \u201cChaihu\u201d in Chinese, is derivedfrom the dried roots of Bupleurum chinenseDC. and Bupleu-rum scorzonerifolium Willd. [1]. As a traditional herbalmedicine, Radix Bupleuri has been used widely for thetreatments of influenza, fever, inflammation, malaria, men-strual disorders, and hepatitis in China, Japan, Korea, andother Asian countries [2, 3]. According to ancient Chinesemedical literatures, Radix Bupleuri is capable of regulatingthe exterior and interior metabolisms, dispersing evil heatfrom the superficies, soothing the liver, and promotingyang and qi (representing \u201clife energy\u201d or \u201clife force\u201d inTCM theories). In recent decades, investigations of RadixBupleuri have focused on its biological activities, includingits anti-inflammatory [4, 5], anticancer [6, 7], antipyretic [8],antimicrobial [9], antiviral [10], hepatoprotective [11], andimmunomodulatory effects [12]. In addition, Radix Bupleurialso exhibited significant effects on membrane fluidity [13].These studies have resulted in the isolation of essential oils,triterpenoid saponins, polyacetylenes, flavonoids, lignans,fatty acids, and sterols from this plant [14]. Among them,triterpenoid saponins are known to be the major bioactivecompounds [15, 16]. Saikosaponins a and d are commonlyused as chemical standards for quality evaluation of RadixBupleuri in the current Chinese Pharmacopoeia and recentpublications. However, an increasing number of recentlypublished studies have reported adverse effects of RadixBupleuri. The purpose of this review is to provide updated,comprehensive information on the traditional uses, botany,phytochemistry, pharmacology, toxicology, and pharmacoki-netics of Radix Bupleuri based on scientific literatures inthe past few decades. This study will facilitate exploringthe therapeutic potential of this plant and evaluate futureresearch opportunities.2. Traditional UsesRadix Bupleuri, which is characterized by a wide spectrumof biological and pharmacological effects, has been used asa famous traditional Chinese medicinal herb with a historyof medical use in China. According to TCM theory, RadixBupleuri is thought to regulate the exterior and interiorHindawiBioMed Research InternationalVolume 2017, Article ID 7597596, 22 pageshttps://doi.org/10.1155/2017/75975962 BioMed Research Internationalmetabolisms, disperse evil heat from superficies, sooth theliver, and promote yang and qi [1].Radix Bupleuriwas initiallyrecorded in Shennong Bencao Jing, a famous monograph oftraditional Chinese medicine written in China in 200 AD[17]. According to a record of traditional Chinese medicinedated 2000 years ago, Radix Bupleuri had mainly been usedfor the treatment of mouth-bitterness, throat-drying, andeyes-dazzling. In other monographs of Materia Medica, suchas Jin Kui Yao Lue, Kaibao Bencao, Bencao Gangmu, andXinbian Bencao, this plant was described to be used for thetreatment of common cold with fever, influenza, hepatitis,malaria, menoxenia, and hyperlipidemia [18]. Currently,Radix Bupleuri exerts other pharmacological effects, suchas balancing different organs and energies within the body,strengthening the action of the digestive tract, improving liverand circulatory system function, and relieving liver tension[19]. Therefore, it is also used as a popular tonic herb inChina. In Korea and Japan, this plant is commonly used forthe treatment of fever, pain, and inflammation associatedwith influenza and the common cold [20]. In addition, thisplant is also used as analgesics in the treatment of distendingpain in the hypochondriac region of the chest and againstamenorrhoea.Radix Bupleuri is combined with other herbs in manyclassical formulas to improve clinical effect. Xiaoyaosan(XYS), a well-known formula for relieving depression, isoriginated from the book of \u201cTaiping Huimin Heji Jufang\u201d inSong Dynasty (960\u20131279 AD), consisting of Radix Bupleuri,Radix Angelicae Sinensis, Radix Paeoniae Alba, RhizomaAtractylodis Macrocephalae, Poria, Radix Glycyrrhizae,HerbaMenthae, and Rhizoma Zingiberis Recens. XYS exerts var-ious pharmacological effects, including soothing the liverand improving the circulation of qi to relieve depression.Furthermore, it has been commonly recognized as a safe andeffective prescription in the treatment of depressive disorder[21\u201323]. The 2015 edition of the Chinese Pharmacopoeialists 97 Chinese patent medicines containing Radix Bupleuri,and the compatible herbs that are more frequently describedincludeRadixGlycyrrhizae,RhizomaZingiberis Recens,RadixScutellariae, and Panax ginseng. Table 1 lists subsets of theChinese patent drugs containing Radix Bupleuri in differentformulations. Although Radix Bupleuri has been used to treatcertain diseases in ethnomedicines for thousands of years,this herbal medicine should be comprehensively understoodand recent information should be obtained for its clinical use.3. Botanical Characterization and DistributionAccording to the Chinese pharmacopoeia, Radix Bupleuri isderived from the dried roots of Bupleurum chinense DC. andBupleurum scorzonerifolium Willd. (Figure 1). The former isknown as \u201cBeichaihu\u201d (Northern Chinese Thorowax Root)and the latter is known as \u201cNanchaihu\u201d (Southern ChineseThorowax Root), due to the difference of the origin anddescription. The drug is collected in spring or autumn,removed from the aerial part and soil, and dried.Beichaihu. As a herbaceous perennial plant, Bupleurum chi-nenseDC. grows to the height of 50\u201385 cm. Its root is conical,taupe, and approximately 6\u201320 cm in length. Its stems areerect, tufted, and apex branched. The leaves are alternate; theleaf blades are broadly linear-lanceolate, 4\u20137 \u00d7 0.6\u20130.8 cm insize; the apex is acuminate. Compound umbels are axillaryand terminal, approximately 1\u20134 cm in length; the bracts are0 or 2-3, linear; the petals are 5 and bright yellow. The fruitsare oblong, brown, and approximately 3mm in length. Theyblossom from July to September and fruit from August toOctober. This plant is widely cultivated in China, Japan, andKorea. Moreover, it grows in grasslands, stream banks, sunnyslopes and roadsides, and other locations with altitudes of100\u20132700m [24].Nanchaihu. Bupleurum scorzonerifolium Willd. is a herba-ceous perennial plant and approximately 30\u201360 cm high. Itsroot is flexuose, reddish brown, and approximately 4\u201310 cmin length. Its stems are 1\u20133, usually glabrous, and apexbranched.The leaf blades are linear or linear-lanceolate, 6\u201316\u00d7 0.2\u20130.7 cm in size; the apex is acuminate. Compoundumbels are axillary and terminal; the bracts are 1\u20133; thepetals are 5 and yellow. The fruits are ellipsoid, dark brown,approximately 2-3mm in length. They blossom from Julyto August and fruit from August to October. This plant isalso widely cultivated in East Asian countries, such as China,Japan, and Korea. It grows in shrub forest margins, sunnymountain slopes, dry grasslands, and other locations withaltitudes of 200\u20133000m [24].There were approximately 36 Bupleurum species andvarieties in different districts and markets due to the slightlydifferent morphologic appearance of Bupleurum plants,including B. longiradiatum Turcz. with toxic ingredients andB. hamiltonii Balak with very little active constituents [25,26]. Inevitably, this situation will compromise the values ofRadix Bupleuri and even imperil the safety of the consumers.Until now, several techniques have been developed to identifyand distinguish them, including TLC [27], HPLC [28\u201330],HPLC-ELSD [31, 32], HPLC-MS [33, 34], UPLC-MS [35], andcapillary electrochromatography [36]. Among thesemethodsmentioned above, HPLC-ELSD is the most commonly usedanalytical method for evaluating the quality and authenticityof Radix Bupleuri. The total amounts of saikosaponins a andd are used as the indicator compounds to characterize thequality of this plant with minimum contents of 0.3% in thePharmacopoeia of People\u2019s Republic of China.4. Chemical ConstituentsIn the past few decades, approximately 74 compounds havebeen isolated from Radix Bupleuri, including essential oils,triterpenoid saponins, polyacetylenes, flavonoids, lignans,fatty acids, and sterols. Triterpenoid saponins, flavonoids,and essential oil, which possess multiple pharmacologicalactivities, are considered as the main active ingredients ofRadix Bupleuri. Their structures are shown in (Table 2)(Figures 2\u20136).4.1. Volatile Compounds (Essential Oils). The essential oils ofRadix Bupleuri are regarded as one of the most importantBioMed Research International 3Table 1: The traditional and clinical uses of Radix Bupleuri in China.Preparation name Compositions Traditional usesXiao Chai HudecoctionRadix Bupleuri, Radix Scutellariae, Panax ginseng,Pinellia ternata, Radix Glycyrrhizae, RhizomaZingiberis Recens, Fructus jujubae.Curing thoracic and hypochondrium fullness,mouth-bitterness, throat-drying, and eyes-dazzlingDa Chai HudecoctionRadix Bupleuri, Radix Scutellariae, Pinellia ternata,Rhizoma Zingiberis Recens, Fructus jujubae, FructusAurantii immaturus, Radix Paeoniae Alba, Rheumpalmatum.Treating diarrhea or constipationChaihu GuizhidecoctionRadix Bupleuri, Radix Scutellariae, Panax ginseng,Pinellia ternata, Radix Glycyrrhizae, RhizomaZingiberis Recens, Fructus jujubae, Radix PaeoniaeAlba, Ramulus cinnamomi.Curing fever with cold aversion, restless arthralgia oflimbs, and epigastric indurationChaihu GuizhiGanjiang decoctionRadix Bupleuri, Ramulus cinnamomi, RhizomaZingiberis, Radix Scutellariae, Radix Glycyrrhizae,Trichosanthes kirilowii, Ostreae Concha.Curing palpitation, fullness of the upper abdomen, anda bitter taste in the mouthChaihu plusMangxiao decoctionRadix Bupleuri, Radix Scutellariae, Panax ginseng,Pinellia ternata, Radix Glycyrrhizae, RhizomaZingiberis Recens, Fructus jujubae, Natrii Sulfas.Curing thoracic and hypochondrium fullness, retchingcounterflow, hot flashes, mouth-bitterness,throat-drying, eyes-dazzling, and constipationChaihu plus LongguMuli decoctionRadix Bupleuri, Radix Scutellariae, Panax ginseng,Pinellia ternata, Rhizoma Zingiberis Recens, Fructusjujubae, Rheum palmatum, Ramulus cinnamomi,Ostreae Concha, Os Draconis, Poria cocos, Minium.Curing thoracic and hypochondrium fullness, difficultyin micturition, and deliriumBuzhong YiqidecoctionRadix Astragali, Radix Bupleuri, Panax ginseng, RadixGlycyrrhizae, Rhizoma Cimicifugae, Radix Angelicaesinensis, Atractylodis Macrocephalae Rhizoma, CitriReticulatae Pericarpium.Curing prolapse of uterus, prolapse of rectum, uterinebleeding, shortness of breath and tiredness, and paletongueChaige Jieji decoctionRadix Bupleuri, Radix Puerariae lobatae, RadixGlycyrrhizae, Radix Scutellariae, Rhizoma et RadixNotopterygii, Radix Angelicae dahuricae, RadixPaeoniae Alba, Radix Platycodonis, Gypsum fibrosum,Rhizoma Zingiberis Recens, Fructus jujubae.Curing mind-cold due to exogenous evils, headache,and vexation and sleeplessnessZheng Chaihu YinRadix Bupleuri, Pericarpium Citri Reticulatae, RadixSaposhnikovia, Radix Paeoniae Rubra, RadixGlycyrrhizae, Rhizoma Zingiberis Recens.Curing mind-cold due to exogenous evils, fever withchilliness, headache, and body painXuefu ZhuyudecoctionRadix Angelicae sinensis, Radix Rehmanniae, SemenPersicae, Flos Carthami, Fructus Aurantii, RadixBupleuri, Radix Glycyrrhizae, Radix Platycodonis,Rhizoma Chuanxiong, Radix Achyranthis Bidentatae,Radix Paeoniae RubraTreating blood pressure related symptoms caused by qistagnation and blood stasis syndromeShengxian DecoctionRadix Astragali, Radix Bupleuri, RhizomaAnemarrhenae, Radix Platycodonis, RhizomaCimicifugae.Curing coronary heart disease, chronic congestive heartfailure, vital myocarditis, and myocardial ischemiaXiaoyao sanRadix Bupleuri, Radix Angelicae Sinensis, RadixPaeoniae Alba, Rhizoma Atractylodis Macrocephalae,Poria, Radix Glycyrrhizae, Herba Menthae, andRhizoma Zingiberis Recens.Soothing the liver and improving the circulation of qi torelieve depressionChaihu Shugan SanRadix Bupleuri, Fructus Aurantii, RhizomaChuanxiong, Rhizoma Cyperi, Pericarpium CitriReticulatae, Radix Paeoniae Rubra, Radix Glycyrrhizae.Curing neurologic impairment, and depressionSini San Radix Bupleuri, Fructus Aurantii, Radix PaeoniaeRubra, Radix Glycyrrhizae.Curing insomnia, liver injury, hepatitis, chronic stressmodel, and palmoplantar hidrosisTongqi San Radix Bupleuri, Rhizoma Cyperi, RhizomaChuanxiong. Curing deafness, tinnitus, and stagnation of liver qiDanzhi Xiaoyao SanRadix Bupleuri, Radix Angelicae Sinensis, RadixPaeoniae Alba, Rhizoma Atractylodis Macrocephalae,Poria, Cortex Moutan, Fructus Gardeniae.Curing headache, menoxenia, distending pain in thelower abdomen, and depression4 BioMed Research InternationalTable 1: Continued.Preparation name Compositions Traditional usesYigan Yiqi Jieyu KeliRadix Bupleuri, Fructus Aurantii, Radix Paeoniae Alba,Radix et Rhizoma Salviae miltiorrhizae, RadixAstragali, Radix Codonopsis, Ramulus cinnamomi,Poria, Acanthopanax senticosus (Rupr. et Maxim)Harms, Fructus trichosanthis, Rhizoma PinelliaePreparatum, and others.Curing chronic hepatitis, hypochondriac pain, bloating,and lassitudeXiao\u2019 er Tuire KeliRadix Bupleuri, Folium isatidis, Radix Isatidis, FlosLonicerae Japonicae, Cortex Moutan, Cape JasmineFruit, Radix Scutellariae, Herba Lophatheri, Pheretima,Rhizoma paridis, Radix et Rhizoma Cynanchi Atrati.Curing cold due to exogenous wind-heat in childrenDalitong KeliRadix Bupleuri, Fructus Aurantii, Radix Aucklandiae,Pericarpium Citri Reticulatae, Pinelliae RhizomaPraeparatum Cum Alumine, Herba Taraxaci, Crataegifructus, Semen Arecae, Paederia scandens, RadixCodonopsis, Rhizoma Corydalis, Massa MedicataFermentata.Curing epigastric fullness, belching, dry mouth, andmouth painBubai KeliFructus Psoraleae, Dolichos lablab L., Folium Epimedii,Radix Bupleuri, Radix et Rhizoma Salviaemiltiorrhizae, Vigna umbellata Ohwi et Ohashi, RadixSophorae Flavescentis, Glycine max (L.) Merr.Nourishing the spleen and warming the kidneysGanmao Qingre KeliSchizonepetae Spica, Radix Bupleuri, Herba menthaehaplocalycis, Radix Saposhnikovia, Perillae Folium,Radix Puerariae lobatae, Radix Platycodonis, SemenArmeniacae amarum, Radix Angelicae dahuricae,Corydalis bungeana Herba.Curing cold, cough, fever, headache, rhinorrhea, andpharyngoxerosisQizhi Weitong tabletRadix Bupleuri, Rhizoma Corydalis, Rhizoma Cyperi,Fructus Aurantii, Radix Paeoniae Alba, RadixGlycyrrhizae.Curing stagnation of liver qi, abdominal distention, andepigastric painLidan tabletRheum palmatum, Flos Lonicerae. Japonicae, HerbaLysimachiae, Radix Aucklandiae, RhizomaAnemarrhenae, Folium isatidis, Radix Bupleuri, RadixPaeoniae Alba, Radix Scutellariae, Natrii Sulfas, HerbaArtemisiae Scopariae.Curing hypochondriac pain, constipation, oliguria withreddish urine, headache, and vomitingRuhe Sanjie tabletRadix Bupleuri, Radix Angelicae sinensis, RadixAstragali, Radix Curcumae, Tulipa edulis, RadixRhapontici, Ecklonia kurome Okam, Sargassum,Folium Epimedii, Herba Pyrolae.Curing lump in breast, and mammary glandhyperplasiaJianwei Yuyang tabletRadix Bupleuri, Radix Paeoniae Alba, RadixCodonopsis, Rhizoma Corydalis, Bletilla striata(Thunb.) Reiehb. f., Indigo Naturalis, ConchaMargaritifera Usta.Curing dysphoria, distention and loose stools, andpeptic ulcerLongdan Xiegan pillRadix et Rhizoma Gentianae, Radix Bupleuri, RadixScutellariae, Fructus Gardeniae, Rhizoma alismatis,Caulis Akebiae, Semen Plantaginis, Radix Angelicaesinensis, Radix Rehmanniae, Radix Glycyrrhizae.Curing hepatochlic hygropyrexia, dizziness, deafness,tinnitus, and mouth-bitternessQingwen Jiedu pillRadix Bupleuri, Folium isatidis, Fructus Forsythiae,Radix Scrophulariae, Radix Trichosanthis, RadixPlatycodonis, Fructus Arctii, Radix Saposhnikovia,Radix Puerariae lobatae, Radix Scutellariae, RadixAngelicae dahuricae, Rhizoma Chuanxiong, and others.Curing headache, throat-drying, and mumpsShugan Hewei pillRhizoma Cyperi, Radix Paeoniae Alba, Fructus citriSarcodactylis, Radix Aucklandiae, Radix Curcumae,Rhizoma Atractylodis Macrocephalae, PericarpiumCitri Reticulatae, Radix Bupleuri, Herba Pogostemonis,Radix Glycyrrhizae, Semen Raphani, and others.Curing disharmony between liver and stomach,epigastric pain, inappetence, and vomitingHuayu Quban capsuleRadix Bupleuri, Radix Scutellariae, Radix Angelicaesinensis, Herba menthae haplocalycis, Flos Carthami,Radix Paeoniae RubraCuring chloasma and acneBioMed Research International 5Table 1: Continued.Preparation name Compositions Traditional usesRuzengning capsuleRadix Bupleuri, Folium Artemisiae Argyi, FoliumEpimedii, Fructus Toosendan, Radix Asparagi,Rhizoma bolbostemmatis.Curing lump in breast and mammary gland hyperplasiaMangan Jieyu capsuleRadix Bupleuri, Radix Angelicae sinensis, RadixPaeoniae Alba, Atractylodis Macrocephalae Rhizoma,Poria, Radix Glycyrrhizae, Herba menthae haplocalycis,Radix et Rhizoma Salviae miltiorrhizae, FructusToosendan, Fructus citri, Rhizoma Corydalis, andothers.Curing chest congestion, inappetence, abdominaldistention, and chronic hepatitisBiyuanshu capsuleRadix Bupleuri, Radix Scutellariae, Herba menthaehaplocalycis, Radix Angelicae dahuricae, FlosMagnoliae, Fructus Xanthii, Fructus Gardeniae, Radixet Rhizoma Asari, Rhizoma Chuanxiong, RadixAstragali, Radix Platycodonis, Poria, Caulis Akebiae.Curing rhinitis and nasosinusitisFigure 1:The whole plant of Bupleurum chinenseDC. (A); the whole plant of Bupleurum scorzonerifoliumWilld. (B); the roots of Bupleurumchinense DC (C); the roots of Bupleurum scorzonerifoliumWilld. (D).bioactive compounds owing to their antifungal and anti-inflammatory activities [37, 38]. In one study, the essentialoils in Radix Bupleuri were extracted by steam distillationand solvent extraction and then analyzed by GC/MS; 78peaks were identified. Among these peaks, the major volatilecompounds were 3-methylbutanal (7.24%), pentanal (5.74%),hexanal (20.11%), furan-2-carbaldehyde (25.23%), and hep-tanal (12.07%) [39]. However, in another study, the resultsshowed that E-2-heptanal, furan, 2-pentyl, and E-2-nonenalwere some of the main compounds of the oil [40].4.2. Triterpenoid Saponins. Triterpenoid saponins are themain active components of Radix Bupleuri, which exhibit abroad spectrum of biological and pharmacological effects,including analgesic, immunomodulatory, hepatoprotective,immunomodulatory, anti-inflammatory, antitumor, andantiviral activities [3, 41\u201343]. Currently, approximately 35saponins have been isolated from Radix Bupleuri (Figure 2)[44\u201354]. Among them, saikosaponins a, c, and d are themajor bioactive constituents found in Radix Bupleuri;however a variety of minor saikosaponins have also beenisolated [16]. The cytotoxic and antiproliferative effects ofsaikosaponins a and d have been attracting much interest inrecent years [55]. Additionally, more information about theintimate relationship between the structural characterizationof saikosaponins and their cytotoxic evaluations is verynecessary.4.3. Polyacetylenes. Four polyacetylene compounds fromRadix Bupleuri have been identified, including (2Z,8Z,10E)-pentadecatriene-4,6-diyne-1-ol (36), (2Z,8E,10E)-pentadec-atriene-4,6-diyne-1-ol (37), (2Z,8Z,10E)-heptadecatriene-4,6-diyne-1-ol (38), and bupleurynol (39) (Figure 3) [56, 57].4.4. Flavonoids. So far, twelve flavonoids have been isolatedand identified from Radix Bupleuri, including quercetin(40), isorhamnetin (41), isorhamnetin-3-O-glucoside (42),puerarin (43), rutin (44), narcissin (45), eugenin (46),saikochromeA (47), saikochromic acid (48), 7,4\udba0\udc20-dihydroxy-isoflavone-7-O-\ud835\udefd-D-glucoside (49), saikochromosideA (50),and saikoisoflavonoside A (51) (Figure 4) [58\u201363].6 BioMed Research InternationalTable 2: Chemical compounds isolated from Radix Bupleuri.Classification Number Chemical component ReferenceSaponins1 Saikosaponin a [44]2 Saikosaponin c [44]3 Saikosaponin d [44]4 Saikosaponin e [45]5 Prosaikogenin G [46]6 Prosaikogenin F [46]7 2\udba0\udc20\udba0\udc20-O-Acetylsaikosaponin a [47]8 3\udba0\udc20\udba0\udc20-O-Acetylsaikosaponin a [48]9 6\udba0\udc20\udba0\udc20-O-Acetylsaikosaponin a [49]10 23-O-Acetylsaikosaponin a [50]11 6\udba0\udc20\udba0\udc20-O-Acetylsaikosaponin d [51]12 23-Hydroxy-13\ud835\udefd, 28\ud835\udefd-epoxy-olean-11-ene-16-one3-O-\ud835\udefd-D-glucopyranosyl-(1\u21923)-\ud835\udefd-D-fucopyranoside [52]13 3\ud835\udefd,16\ud835\udefd-Dihydroxy-23-O-acetyl-13\ud835\udefd, 28\ud835\udefd-epoxy-olean-11-ene3-O-\ud835\udefd-D-fucopyranoside [47]14 Bupleuroside I [45]15 Saikosaponin b1 [45, 49]16 Saikosaponin b2 [45, 49]17 6\udba0\udc20\udba0\udc20-O-Acetyl-saikosaponin b2 [51]18 Saikosaponin h [47, 53]19 Prosaikogenin D [54]20 Prosaikogenin A [47]213\ud835\udefd,23,28-Trihydroxy-11, 13(18)-diene-16-one3-O-\ud835\udefd-D-glucopyranosyl-(1\u21923)-\ud835\udefd-D-fucopyranoside[47]22 Bupleuroside V [45]23 Bupleuroside X [45]24 Bupleuroside XII [45]25 Saikosaponin v-1 [51]26 Saikosaponin b3 [44, 53]27 Saikosaponin b4 [44, 53]28 Saikosaponin f [45]29 3\ud835\udefd,16\ud835\udefd,23,28-Tetrahydroxy-11\ud835\udefc-methoxy-olean-12-ene3-O-\ud835\udefd-D-fucopyranoside [47]30 3\ud835\udefd,16\ud835\udefd,28-Trihydroxyl-11\ud835\udefc-methoxy-olean-12-ene-O-\ud835\udefd-D-fucopyranoside [47]31 Bupleuroside VII [45]32 Saikosaponin g [53]33 Saikosaponin i [53]34 Bupleuroside VIII [45]35 Bupleuroside XI [45]Polyacetylenes36 (2Z,8Z,10E)-pentadecatriene-4,6-diyne-1-ol [56]37 (2Z,8E,10E)-pentadecatriene-4,6-diyne-1-ol [56, 57]38 (2Z,8Z,10E)-heptadecatriene-4,6-diyne-1-ol [56]39 Bupleurynol [56, 57]BioMed Research International 7Table 2: Continued.Classification Number Chemical component ReferenceFlavonoids40 Quercetin [60]41 Isorhamnetin [60]42 Isorhamnetin-3-O-glucoside [60]43 Puerarin [60]44 Rutin [60]45 Narcissin [59]46 Eugenin [62]47 Saikochrome A [62, 63]48 Saikochromic acid [60]49 7,4\udba0\udc20-Dihydroxy-isoflavone-7-O-\ud835\udefd-D-glucoside [60]50 Saikochromoside A [59]51 Saikoisoflavonoside A [61]Lignans52 Nortrachelogenin [63]53 Nemerosin [62]54 Kaerophyllin [62]55 Isochaihulactone [62]56 Isokaerophyllin [62]57 (\u2212)-yatein [62]58 Chinensinaphthol [62]59 Chaihunaphthone [62]Fatty acids60 Fumaric acid [64]61 Butanedioic acid [64]62 Pentadecanoic acid [65]63 Palmitoleic acid [65]64 Palmitic acid [65]65 Oleic acid [65]66 Stearic acid [65]67 11-Hexadecenoic acid [65]68 13-Octadecenoic acid [65]69 Linoleic acid [65]70 Tetracosanoic acid [64]71 9S,12S,13S-Trihydroxy-10E-octadecenoic acid [63]Sterols72 \ud835\udefc-Spinasterol [64]73 24\ud835\udf09-Methylcholesta-7, 22E-diene-3\ud835\udefd,5\ud835\udefc,6\ud835\udefd-triol [63]74 24\ud835\udf09-Ethylcholest-22E-end-3\ud835\udefd,5\ud835\udefc,6\ud835\udefd-Triol [63]4.5. Ligans. Lignans existing in numerous plants weredetected in the roots of Bupleurum scorzonerifolium Willd.These lignans included nortrachelogenin (52), nemerosin(53), kaerophyllin (54), isochaihulactone (55), isokaero-phyllin (56), (\u2212)-yatein (57), chinensinaphthol (58), andchaihunaphthone (59) (Figure 5) [62, 63].4.6. Other Compounds. There are also other components inRadix Bupleuri, including 12 fatty acids: fumaric acid (60),butanedioic acid (61), pentadecanoic acid (62), palmitoleicacid (63), palmitic acid (64), oleic acid (65), stearic acid(66), 11-hexadecenoic acid (67), 13-octadecenoic acid (68),linoleic acid (69), tetracosanoic acid (70), and 9S,12S,13S-trihydroxy-10E-octadecenoic acid (71). Three sterols com-pounds, namely, \ud835\udefc-spinasterol (72), 24\ud835\udf09-methylcholesta-7, 22E-diene-3\ud835\udefd,5\ud835\udefc,6\ud835\udefd-triol (73), and 24\ud835\udf09-ethylcholest-22E-end-3\ud835\udefd,5\ud835\udefc,6\ud835\udefd-triol (74) were also isolated and identified fromthis plant (Figure 6) [63\u201365].5. Pharmacological EffectsRadix Bupleuri exerts a great variety of pharmacologi-cal activities due to its complexbioactive compounds. Anoverview of the pharmacological studies on Radix Bupleuriispresented in detail in the following sections.8 BioMed Research InternationalOR1R1 R2 R3 R4R2R1R1 R2R1 R2R3R3 R4R1R1R2R2R3R1R1R1R2R3CH2R2CH2R3CH2R2CH2OHCH2OHCH2OHCH2OHR3OR4OR4OR3OR2O\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fd-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OH\u0001\ud6fc-OHOHOHOHOHOHOHOHOHOHOH1234567891011121314151617181920212223242526272829303132333435HHOAcOAc=O=O=OCOOHCOOH\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Fuc-2\u000f\u3c00\u000f\u3c00-Acetyl-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-3\u000f\u3c00\u000f\u3c00-Acetyl-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-6\u000f\u3c00\u000f\u3c00-Acetyl-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-6\u000f\u3c00\u000f\u3c00-Acetyl-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-2)-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3CH3COOCH2-(CHOH)3-CH2OHCH2OHCH2OH\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-6\u000f\u3c00\u000f\u3c00-acetyl-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-OCH3OCH3OCH3OHOHOHOHOCH3HHHHH\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Glc-(1-3)-\u0001\ud6fd-D-Fuc-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-\u0001\ud6fd-D-Glc-(1-2)-\u0001\ud6fd-D-Ara-(1-3)-\u0001\ud6fd-D-GlcA-\u0001\ud6fd-D-Glc-(1-6)-[\u0001\ud6fc-L-rha-(1-4)]-\u0001\ud6fd-D-Glc-Figure 2: Chemical structures of triterpenoid saponins.BioMed Research International 9OHOH37363938OHOHFigure 3: Chemical structures of polyacetylenes.5.1. Anti-inflammatory Effects. Radix Bupleuri has beenwidely used for the treatment of several types of chronicinflammatory diseases. The crude polysaccharides(80mg/kg) isolated from the roots of Bupleurum chinenseDC. significantly attenuated lung injury by inhibiting thelevel of myeloperoxidase (MPO), tumor necrosis factor-\ud835\udefc(TNF-\ud835\udefc), and serum nitric oxide (NO) [66]. Chun et al.reported that saikosaponins from Radix Bupleuri exhibitedanti-inflammatory activity on inflammatory processesincluding inhibition of inflammatory exudation, capillarypermeability, inflammatory mediators release, migrationof white cells, connective tissue hyperplasia, and a varietyof allergic inflammation [67]. Ma et al. was the first toshow that saikosaponins exerted anti-inflammatory activityon paw edema mainly via regulating the nicotinate andnicotinamide metabolism and arachidonic acid metabolism[5]. Zhu et al. found that saikosaponin a (SSa) exhibitedan inhibitory effect on proinflammatory cytokines inLPS-stimulated macrophages. The mechanism of theseactions involved the regulation of MAPK and NF-\ud835\udf05B signalspathways [68]. In another study, SSa dose-dependentlyinhibited the production of ROS, TNF-\ud835\udefc, IL-8, COX-2, andiNOS in LPS-stimulated human umbilical endothelial cells(HUVECs) by upregulating of the LXR\ud835\udefc-ABCA1 signalingpathway [69]. Moreover, Lee et al. showed that saikosaponinc (SSc) was also shown to inhibited LPS-induced apoptosis inHUVECs via inhibition of caspase-3 activation and caspase-3-mediated-FAK degradation [70]. Zhao et al. showed thatSSa also suppressed TNF-\ud835\udefc and IL-6 concentrations inthe intestines of septic rats through the inhibition of thenucleotide-binding oligomerization domain 2 (NOD2)/NF-\ud835\udf05B signaling pathway [71]. Saikosaponin d (SSd) has beenreported to inhibit PGE2 production and intracellular freeCa2+ concentration ([Ca2+]i) in a concentration-dependentmanner with an IC50 value of 3 \ud835\udf07m in C6 rat glioma cells[72].In addition, several studies showed that a widerange of Radix Bupleuri preparations also exhibited anti-inflammatory effects in in vitro and in vivo model. Li et al.showed that Saireito and its active components (SSd) couldsuppress the proliferation of mesangial cells and expansionof the mesangial matrix in the rat glomerulonephritismodel [73]. In experimental chronic pancreatitis rats model,\u201cChai-hu-shu-gan powder\u201d exerted anti-inflammatory andantifibrotic effects by inhibiting the expression of nuclearfactor-\ud835\udf05B (NF-\ud835\udf05B) and TNF-\ud835\udefc mRNA in the pancreas [74].Furthermore, it also reduced the abnormally high plasmalevel of cholecystokinin, improved the gastricmovement, andavoided nausea and flatulence [75]. In another experiment,a Chinese herbal formula called \u201cRCM-101\u201d (containingFlos magnoliae, Radix Bupleuri, Radix Glycyrrhizae, RadixAngelicae Sinensis, etc.) inhibited the NO production andiNOS protein expression in LPS-stimulated rat aorta andRaw 264.7 macrophages [76].5.2. Anticancer Effects. The extracts and compounds ofRadix Bupleuri also possessed anticancer/antitumor effect.The acetone extract of Bupleurum scorzonerifolium couldinhibit the proliferation of A549 human lung cancer cellsin a dose-dependent manner via causing cell cycle arrestin the G2/M phase, increasing microtubule stabilization,suppressing telomerase activity, activating ERK 1/2 andcaspase-3/9 in A549 cells [77\u201379]. Saponins isolated fromRadix Bupleuri also exhibited significantly anti-proliferativeactivity in human non-small cell lung cancer A549 cellsthrough Fas-dependent apoptotic pathway [80]. Su et al.found that thewater extracts ofRadix Bupleuri could enhance5-fluorouracil-induced cytotoxicity in HepG2 hepatoma cellsthrough cell arrest at the late G1/early S phase, while pro-tecting normal blood lymphocytes [6]. SSd showed verypotent activity against the HepG2 cell line with an IC50value of 12.5mg/ml. The mechanism of cytotoxicity was10 BioMed Research InternationalOOOOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOHOH41404342OOOOOOOOOOHOOOOOOOOOO44 45OOOOOOCOOH46 4847O OOO OOO49 50OOOOOO51CH2OCH2OHCH2OHCH2OHCH3CH2OHCH2OHHOH2CH3CH3COH3COH3COH3COCH3OCH3OCH3OCH3Figure 4: Chemical structures of flavonoids.attributed to the induction of apoptosis through activationof caspase-3 and caspase-7, which subsequently resultedin poly-ADP-ribose polymerase (PARP) cleavage [81]. Thestudy by Hou et al. demonstrated that SSd exerted itsantitumor effect in human hepatocellular carcinoma cellline SMMC-7721 through the HIF-1\ud835\udefc/COX-2 pathway [82].Furthermore, SSd was also reported to induce autophagyin HeLa and MCF-7 cancer cells by direct inhibition ofBioMed Research International 11O OHOHHOHO52HOOOORHOHOOORHOOO OH H53 55565754OOOOHOOOOO58 59 OCH3OCH3OCH3OCH3OCH3OCH3OCH3OCH3H3COH3COH3COH3COH3COH3COR = OCH3R = HR = OCH3R = HFigure 5: Chemical structures of lignans.sarcoplasmic/endoplasmic reticulumCa2+ ATPase (SERCA),leading to the increase of intracellular calcium ion levels andactivating the Ca2+/calmodulin-dependent kinase kinase-\ud835\udefd- (CaMKK\ud835\udefd-) AMP-activated protein kinase- (AMPK-)mammalian target of rapamycin (mTOR) signaling cascade,endoplasmic reticulum (ER) stress, and unfolded proteinresponses (UPR) [43].Several Chinese medicine preparations containing RadixBupleuri also have been traditionally used in the treatmentof tumors and cancer. The water extracts of \u201cLong DanXie Gan Wan\u201d exerted a significant growth inhibitory effectin HL60 and HT29 cancer cell lines, indicating that thisformulation may possess some chemotherapeutic potential[83]. Treatment with \u201cxiao-chai-hu decoction\u201d exhibited asignificantly lower incidence of hepatocellular carcinoma andreductions in cancer pain and tumor size. The underlyingmechanismof the antitumor activities is based on stimulationof the reticuloendothelial system (RES) and is closely relatedof TNF production [84\u201386].5.3. Antiviral Effects. Wen et al. reported that the acetoneextract of Radix Bupleuri possessed a significant antiviruseffect on acute respiratory tract infections with H1N1 virusinfection and suppressed influenzaAvirus-inducedRANTESsecretion in H1N1-infected A549 cells at a concentration of100 and 200\ud835\udf07g/ml, suggesting that Radix Bupleuri might bebeneficial for the treatment of chronic inflammatory condi-tions followed by viral infection [10]. SSc has been reportedto show effective anti-HBV activity through inhibiting DNAexpression of HBsAg, HBeAg, and HBV [81]. Treatmentwith \u201cxiao-chai-hu decoction\u201d (20\ud835\udf07g/ml, 3 days; 20\ud835\udf07g/ml,6 days) could inhibit the production of HBV (\ud835\udc43 < 0.0001)and the expression of HBeAg. Moreover, crude saponinsof Bupleurum chinense DC. could inhibit the replication ofHBV (\ud835\udc43 < 0.0001) [87]. Similarly, in another study, Yinet al. showed that SSd isolated from the MeOH extract ofBupleurum chinense DC. exhibited significant bioactivity ininhibitingDNA replication ofHBV [88].The antiviral activityof saikosaponins (a, b2, c, and d) and their mode of actinwere examined. The results showed that all saikosaponinsexerted antiviral activity on human coronavirus-229E atconcentrations of 0.25\u201325\ud835\udf07m, and the strongest activity wasobserved for saikosaponin b2 with an IC50 of 1.7 \ud835\udf07m. Thismechanism might involve interference in the early stage ofviral replication, such as absorption and penetration of thevirus [89].5.4. Antipyretic Effects. The water extract of Radix Bupleuriwas reported to exert its antipyretic effect on dry yeast-induced high fever rats. The mechanism is related to the12 BioMed Research InternationalOOOOOHOHOHOHOHOHOHOHOHOHOHHOHOHOHOHOHOHOHOHOOH HOHOO60 61 62OOHO63 64O65O66O67O68O69O70O71HHHHH72 73H74Figure 6: Chemical structures of other compounds.adjustment of synthesis and exudation of cyclic adenosinemonophosphate (cAMP) and arginine vasopressin (AVP)[90]. A novel in situ gel system for nasal delivery of theessential oil from Radix Bupleuri was prepared. The resultssuggested that Radix Bupleuri in situ gel can be moreeffective than the solution in the treatment of fever [91]. Asimilar study showed that the essential oil extracted from theherb exhibited dose-dependent antipyretic capacity on bothfevered rabbits and rats [92].5.5. Antibacterial Effects. The ethanol extract of Bupleu-rum chinense DC. exerted a remarkable bacteriostaticeffect on Gram-negative microorganism Helicobacter pylori.The bioactive minimum inhibitory concentration (MIC)BioMed Research International 13value was 60Mm [93]. Saikosaponins isolated from RadixBupleuri have been reported to exhibit antibacterial activity,particularly against Pseudomonas aeruginosa and Listeriamonocytogenes. The protective effect was attributed to theimmunomodulatory action on macrophages [94]. \u201cChaihuinjection\u201d has also been tested for possible antimicrobialactivity in vitro.The results demonstrated thatmild inhibitionof Staphylococcus aureus was observed but no effects wereobserved against Staphylococcus albus,Neisseria gonorrhoeae,Diplococcus pneumoniae, haemolytic Streptococcus, or Pseu-domonas aeruginosa [95].5.6. Hepatoprotective Effects. The liver protective effectsagainst CCl4 induced liver injury were investigated aftertreatment ofmicewith raw and vinegar-bakedRadix Bupleuri(5 g/kg/day) for 14 days. The results showed that both rawand processed Radix Bupleuri showed liver protective effectsagainst CCl4 induced liver injury, and the vinegar-bakedRadix Bupleuri exerted better effects than that of raw RadixBupleuri [96]. Pretreated with saikosaponins, especially SSaor SSd, showed remarkable inhibition of D-galactosamine-induced hepatic injury through decreasing the activity ofglucose-6-phosphatase and NADPH-cytochrome C reduc-tase and increasing 5\udba0\udc20-nucleotidase activity [97]. Similarly,bupleurosides III, VI, IX, and XIII and saikosaponin b3isolated from Bupleurum scorzonerifolium Willd. were alsofound to exhibit protective effect on the D-galactosamine-induced cytotoxicity in primary cultured rat hepatocytes[98]. Further studies also demonstrated that the protectiveeffects of saikosaponins isolated from Bupleurum chinenseDC. could prevent hepatocyte injury through regulatingintracellular calcium levels [99]. In a rat model with CCl4induced acute hepatic injury, the hepatic enzyme levels (GOT,GPT, and ALP) and the lipid peroxidation in the liver weresignificantly reduced by the administration of SSd [100].Additionally, SSd significantly reduced collagen I depositionand alanine aminotransferase level on liver fibrosis rats anddecreased the concentration of transforming growth factor\ud835\udefd1 (TGF-\ud835\udefd1). Moreover, SSd was able to alleviate hepatocyteinjury from oxidative stress.The effect of SSd on liver fibrosismay be related to its ability to reduce lipid peroxidation [101].5.7. Immunomodulatory Effects. Yamakage et al. determinedthe effects of Radix Bupleuri on spontaneous lymphaticvessel activity. The results indicated that Radix Bupleurisignificantly increased the amplitude of spontaneous activityof lymphatic vessels in a concentration-dependent manner,and the mechanisms of this effect seem to be independent ofendothelial function [102]. Eugenin (46) and saikochrome A(47) isolated from the MeOH extracts from Bupleurum scor-zonerifolium possessed immunosuppressive effect on humanperipheral blood T cells via inhibiting CD28-costimulatedactivation [62]. SSd (10mg, intraperitoneally) significantlyactivated peritoneal macrophages in terms of enhancementof phagocytic activity, increased level of cellular lysosomalenzyme, and suppressed the response of plaque-forming cellsto heterologous erythrocytes by stimulating T and B cells ina dose-dependent manner [103]. Moreover, SSd modulatedlymphocyte activity through suppressing the T cell responseand increasing the B cell response to different mitogensand the interleukin- (IL-) 2/IL-4 production through areceptor-bypassed pathway [41, 104, 105]. In another exper-iment, Wong et al. found that SSd was shown to inhibitOKT3/CD28-costimulated human T cell proliferation andPMA, PMA/ionomycin, and Con A-induced mouse T cellactivation in vitro. The underlying mechanisms involveddownregulation of NF-kB signaling by suppression of IKKand Akt activities [106].5.8. Autophagic Effect. Autophagy is a complex processin cells, which occurs through the formation of double-membrane vesicles (autophagosomes), which are engulfedby cytoplasmic molecules. Then, the autophagosome fuseswith the lysosomes, leading to degradation of long-livedproteins, aggregated proteins, and damaged organelles [107\u2013109]. Moreover, autophagy might be triggered by hypoxia,nutritional deprivation, radiation, chemical drugs, and otherstimulants [110]. Autophagy contributes to the pathogenesisof diverse diseases, such as neuronal degeneration, inflamma-tory bowel disease, aging, and cancer [111, 112]. In the previousstudy, Law et al. demonstrated that the protective pharma-cological effects of Radix Bupleuri might be attributed to itsautophagy induction.The autophagic effect of Radix Bupleuriplayed an important role in relieving liver disease-relatedsymptoms through anti-inflammatory, organ-protective, andaggregate removal functions. Furthermore, the anticancereffects of Radix Bupleuri could be attributed to its autophagyinduction. Radix Bupleuri has been found to be an effectivetreatment against depression by regulating metabolite, hor-mone, and neurotransmitter levels via autophagy-mediatedlipid metabolism [113].5.9. Other Pharmacological Effects. The effect of the ethanolextract from Radix Bupleuri on cytochrome 450 isoformactivities using a six-drug cocktail approach was evaluated;the results demonstrated that Radix Bupleuri had stronginduction activity on the CYP2E1, CYP2D6, and CYP3A4,which may lead to potential plant drug-drug interactions[114]. Radix Bupleuri was shown to be the inhibitor of \ud835\udefd-glucuronidase. The inhibition rate of Radix Bupleuri extractsRB1 (high molecular weight polysaccharides), RB2 (ethanolsoluble/water insoluble component), RB3 (extracted by n-butanol, soluble in water), and RB4 (low molecular weightwater soluble parts) on the activity of \ud835\udefd-glucuronidase wasfound to be 45.15%, 33.94%, 24.94%, and 34.54%, respectively[115]. In pentylenetetrazol (PTZ) induced epilepsy ratsmodel,SSa isolated fromRadix Bupleuri significantly reduced seizureseverity and duration while it markedly elevated seizurelatency and downregulated the cytokines expression of p-mTOR, p-70S6K, L-1\ud835\udefd, and TNF-\ud835\udefc through inhibitingmTORsignaling pathway [116]. He et al. demonstrated that SSa obvi-ously reduced lipoprotein uptake to block foamcell formationand the expression of LOX-1 and CD36, boosted cholesterolefflux, and the expression of ABCA1 and PPAR\ud835\udefe throughinhibiting PI3K/Akt/NF-\ud835\udf05B/NLRP3 signaling pathway [117].14 BioMed Research InternationalIn another experiment, SSc exerted a potent effect on induc-ing human umbilical vein endothelial cells (HUVECs) via-bility and growth. Furthermore, SSc also induced endothelialcells migration and capillary tube formation. The underlyingmechanisms might be related to the gene expression oractivation of matrix metalloproteinase-2 (MMP-2), vascularendothelial growth factor (VEGF), and the p42/p44mitogen-activated protein kinase (MAPK, ERK) [118]. In addition, SScwas shown to exhibit inhibitory activities against Alzheimer\u2019sdisease (AD) via suppressing the secretion ofA\ud835\udefd peptides andabnormal tau hyperphosphorylation-mediated microtubuledepolymerization. Moreover, SSc suppressed A\ud835\udefd peptide-induced brain endothelial apoptosis, indicating that Sscmight be a novel therapeutic tool for treating human AD andother neurodegenerative diseases [119]. It was shown by Liuet al. for the first time that four polyacetylenes (36\u201339) fromRadix Bupleuri potently exhibited an antidepressant activityby inhibiting the reuptake of serotonin, norepinephrine, anddopamine. The mechanism might be mediated by increasingthe level of monoamines, particularly 5-HT andNE [56]. Zhuet al. suggested that SSa and SSd exhibited the anthelminticactivity against Dactylogyrus spp. infecting goldfish. Theeffective concentration (EC50) values for SSa and SSd were1.46 and 0.74mg\u22121, respectively [120].5.10. Summary of Pharmacological Effects. Radix Bupleuripossesses awide spectrumof pharmacological effects, includ-ing anti-inflammatory effect, anticancer effect, antiviraleffect, antipyretic effect, antibacterial effect, hepatoprotectiveeffect, and immunomodulatory effect (Table 3). Based onthese pharmacological effects, we can conclude that theextracts and the compounds from this plant can preventor treat certain diseases, such as cancer, fever, malaria,hepatitis, and AD. However, there is not enough systemicdata of these chemical compounds and their pharmacologicaleffects. Thus, in the future, the pharmacological effects andthe possible molecular mechanisms of the pharmacologicalactivities of Radix Bupleurimust be urgently explored on ourmodern understanding of these diseases\u2019 pathophysiologies.6. ToxicologyRadix Bupleuri has been used for thousands of years asan important traditional herb in China. However, the toxiceffects of Radix Bupleuri in clinical applications have beengradually reported. Several studies have found that the liveris the main organ affected by toxicity, particularly in long-term use. Major symptoms of liver injury induced by RadixBupleuri included transaminase lifts, hepatitis, and jaundice.However, liver functions can return to normal levels aftera specific period [121]. Radix Bupleuri has been reportedto exhibit acute hepatitis and acute hepatic necrosis. Themean total daily dose was 18.0 \u00b1 33.5 g, which was morethan the Chinese Pharmacopoeia recommended range of 3to 10 g [122]. Moreover, Radix Bupleuri had been implicatedinmultiple cases of acute hepatitis both as an ingredient aloneand within a particular formulation \u201cXiao-Chai-Hu-Tang\u201d(also known as Syo-Saiko-To in Japanese) [123]. Lee et al.demonstrated that two Chinese herbal products containingRadix Bupleuri might increase their risks of liver injuryin HBV-infected patients. However, further mechanisticresearch on the hepatotoxicity of Radix Bupleuri in thepresence ofHBV infection is warranted [124]. In addition, theessential oil of Radix Bupleuri induced acute hepatotoxicitywith asynchronous state, higher heart rate, and fast breathing[125]. The total saponins isolated from Radix Bupleuri couldalso cause evidently liver damage in dose-dependent mannermanifested as hepatocyte organic lesion and liver functionchanges, as well as hepatocyte death [126].7. PharmacokineticsA selective and sensitive LC-MS/MS method was developedand validated for simultaneous determination of SSa, b2, c,and d in rat plasma afteroral administration of the ethanol-water (50 : 50, v/v) extract of Radix Bupleuri for the firsttime. The results demonstrated that SSa, c, and d wereabsorbed rapidly with \ud835\udc47max less than 30min [127]. In anotherpharmacokinetics experiment of rats, Liu et al. was the first todevelop an UPLC-PDA-MS method to determine the phar-macokinetics of four polyacetylenes after i.g. administrationof 95% ethanol extract of Radix Bupleuri. The results showedthat compounds 36 and 38 were not detected in rat serum,whereas compounds 37 and 39 exerted a fast distributionphase followed by a relatively slow elimination phase (\ud835\udc611/2\ud835\udc67,4\u20137 h) [56].8. Future Perspectives and ConclusionsIn traditional Chinese medicine, Radix Bupleuri has longbeen used regulate the exterior and interiormetabolisms, dis-perse evil heat from superficies, sooth the liver, and promoteyang and qi. It has been widely used to treat various diseasesin China, Japan, Korea, and other Asian countries for manycenturies. A total of 74 compounds including essential oils,triterpenoid saponins, polyacetylenes, flavonoids, lignans,fatty acids, and sterols have been isolated and identifiedfrom Radix Bupleuri [39\u201365]. Pharmacological studies haverevealed that Radix Bupleuri possesses a variety of biologicaleffects, including anti-inflammatory, anticancer, antiviral,antipyretic, antibacterial, antiobesity, immunomodulatory,hepatoprotective, neuroprotective, and autophagic effects[66\u2013120]. However, there are some aspects that need to befurther investigated.Radix Bupleuri is an ingredient of many patent medicinesor prescriptions. Although modern experiments have con-firmed that this drug alone exhibits multiple pharmacolog-ical activities, it is important to investigate the molecularmechanisms of Radix Bupleuri combined with other herbsbased on traditional uses. Furthermore, the pharmacologicaleffects of only a few of the ingredients, such as saikosaponins,flavonoids, and the essential oils, have been investigated.Some polyacetylenes, lignans, and sterols have not beensufficiently researched in terms of their pharmacologicaleffects. Radix Bupleuri shows both hepatoprotection andBioMed Research International 15Table3:PharmacologicaleffectsofRadixBupleuri.PharmacologicaleffectsCelllines/modelDetail/mechanism(s)ofactionPreparations/extracts/compoundsApplicationReferenceAnti-inflammatoryeffectLPS-inducedmouseacutelunginjuryIncreaseslevelsofMPOandTNF-\ud835\udefc;InhibitstheNolevelCrudepolysaccharidesInvivo[66]Formalin-inducedmicepawedemaRegulatesthenicotinateandnicotinamidemetabolismandarachidonicacidmetabolismSaikosaponinsInvivo[5]LPS-stimulatedRAW264.7cellsRegulatesMAPKandNF-\ud835\udf05BsignalspathwaysSaikosaponinaInvitro[68]LPS-stimulatedhumanumbilicalendothelialcellsActivatestheLXR\ud835\udefc-ABCA1signalingpathwaySaikosaponinaInvitro[69]SepticratsmodelInhibitsthenucleotide-bindingoligomerizationdomain2(NOD2)/NF-\ud835\udf05BsignalingpathwaySaikosaponinaInvivo[70]LPS-inducedapoptosisinhumanumbilicalveinendothelialcellsInhibitsthecaspase-3activationandcaspase-3-mediated-FAKdegradationSaikosaponincInvitro[71]C6ratgliomacellsInhibitsPGE 2productionandelevatesintracellularfreeCa2+concentrationSaikosaponindInvitro[72]MonoclonalantibodyinducednephritisSuppressesproteinuria,proliferationofmesangialcells,andexpansionofthemesangialmatrixSaikosaponindInvivo[73]ChronicpancreatitisratsmodelInhibitstheexpressionofNF-\ud835\udf05BandTNF-\ud835\udefcmRNAChai-hu-shu-ganpowderInvivo[74]LPS-stimulatedrataortaandRaw264.7macrophagesInhibitstheNOproductionandiNOSproteinexpressionRCM-101Invivo/invitro[76]AnticancereffectA549humanlungcancercellsSuppressestelomeraseactivityandactivatesERK1/2andcaspase-3/9AcetoneextractsInvitro[77\u201379]Humannon-small-celllungcancerA549cellsRegulatesFas-dependentapoptoticpathwaySaponinsInvitro[80]HepG2hepatomacellsInducescellarrestatthelateG1/earlySphaseWaterextractsInvitro[6]HepG2celllineActivatescaspase-3andcaspase-7SaikosaponindInvitro[81]SMMC-7721celllineRegulatestheHIF-1\ud835\udefc/COX-2pathwaySaikosaponindInvitro[82]HeLaandMCF-7cancercellsInhibitstheSERCA;ActivatestheCaMKK\ud835\udefd-AMP-AMPK-mTORsignalingcascade,ERstressandUPRSaikosaponindInvitro[43]16 BioMed Research InternationalTable3:Continued.PharmacologicaleffectsCelllines/modelDetail/mechanism(s)ofactionPreparations/extracts/compoundsApplicationReferenceAntiviraleffectH1N1-infectedA549cellsAnti-H1N1virusAcetoneextractsInvitro[10]HBV-transfectedhumanhepatomacellsInhibitsDNAexpressionofHBsAg,HBeAg,andHBVSaikosaponincInvitro[81]HBV-transfectedhumanhepatomacellsInhibitstheproductionofHBVandtheexpressionofHBeAgCrudesaponinsInvitro[87]HBV-transfectedhumanhepatomacellsInhibitsDNAreplicationofHBVMeOHextractsInvitro[88]Humancoronavirus-229EInterfereswiththeearlystageofviralreplicationSaikosaponinsInvitro[89]AntipyreticeffectDryyeast-inducedhighfeverratsAdjuststhesynthesisandexudationofcAMPandAVPWaterextractsInvivo[90]Turpentine-inducedfeverrabbitsDecreasesbodytemperatureTheessentialoilInvivo[91]Turpentine-inducedfeverrabbitsandratsDecreasesbodytemperatureTheessentialoilInvivo[92]AntibacterialeffectHelicobacterpyloristrainAnti-HelicobacterpyloriEthanolextractsInvitro[93]StaphylococcusaureusstrainAnti-StaphylococcusaureusChaihuinjectionInvitro[95]Pseudomonasaeruginosa,ListeriamonocytogenesstrainsAnti-Pseudomonasaeruginosa,Anti-ListeriamonocytogenesSaikosaponinsInvitro[94]HepatoprotectiveeffectCCl 4inducedhepaticdamageinratsHepatoprotectiveeffectsMethanolextractsInvivo[96]D-galactosamine-inducedhepaticinjuryinratsDecreasestheactivityofglucose-6-phosphataseandNADPH-cytochromeCreductase;increases5\udba0\udc20-nucleotidaseactivitySaikosaponinsInvivo[97]D-galactosamine-inducedcytotoxicityinrathepatocytesHepatoprotectiveeffectsBupleurosidesIII,VI,IX,andXIII;saikosaponinb 3Invitro[98]BEL-7402cellsRegulatesintracellularcalciumlevelsSaikosaponinsInvitro[99]CCl 4inducedacutehepaticinjuryinratsHepatoprotectiveeffectsSaikosaponindInvivo[100]CR-1548cell;liverfibrosisinratsReduceslipidperoxidationSaikosaponindInvitro/invivo[101]ImmunomodulatoryeffectRatsfedwithRadixBupleuriIncreasestheamplitudeofspontaneousactivityoflymphaticvesselsWaterextractsInvivo[102]HumanperipheralbloodTcellsInhibitsCD28-costimulatedactivationMeOHextractsInvitro[62]BALB/c,C3H/HeandCDF 1miceStimulatesTandBcellsSaikosaponindInvivo[103]Thymocytesandspleencells;C57BL/6miceRegulatesreceptor-bypassedpathwaySaikosaponindInvitro/invivo[41,104,105]BioMed Research International 17Table3:Continued.PharmacologicaleffectsCelllines/modelDetail/mechanism(s)ofactionPreparations/extracts/compoundsApplicationReferenceOthersMaleSDratsExhibitsstronginductionactivityontheCYP2E1,CYP2D6,andCYP3A4EthanolextractsInvivo[107]PTZ-inducedepilepsyratsmodelInhibitsmTORsignalingpathwaySaikosaponinaInvivo[109]THP-1CellsInhibitsPI3K/Akt/NF-\ud835\udf05B/NLRP3signalingpathwaySaikosaponinaInvitro[110]HumanumbilicalveinendothelialcellsActivatesMMP-2,VEGF,andthep42/p44mitogen-activatedproteinkinaseSaikosaponincInvitro[111]SH-SY5YandSK-N-SHcelllinesSuppressesthesecretionofA\ud835\udefdpeptidesSaikosaponincInvitro[112]MaleWistarratsIncreasesthelevelof5-HTandNEPolyacetylenesInvivo[56]Dactylogyrusspp.infectinggoldfishAnthelminticactivitySaikosaponinsaanddInvivo[113]18 BioMed Research Internationalhepatotoxicity, which appears to be contradictory. This phe-nomenon is similar to that of PolygonummultiflorumThunb.[128]. Based on the literature, the main reasons are likelythe administration dosage and delivery time. High doses andlong-term drug delivery are more likely to result in livertoxicity, whereas low doses and short-term drug deliverymight result in liver protection. Therefore, this issue needsfurther study.In conclusion, this review summarized the traditionaluses, botany, phytochemistry, pharmacology, and toxicologyof Radix Bupleuri. Moreover, it has provided a new founda-tion for further research on its mechanism of action and thedevelopment of better therapeutic agents employing RadixBupleuri in the future. It is anticipated that the comprehen-sive and detailed research on toxicity, pharmacodynamics,pharmacokinetics, and molecular mechanism are necessaryto be explored to develop its bioactive compounds as effectivedrugs.Conflicts of InterestThe authors have declared that there are no conflicts ofinterest regarding the publication of this paper.Authors\u2019 ContributionsFude Yang and Xiaoxv Dong contributed equally to this workand share first authorship.AcknowledgmentsThis work was financially supported by the CollaborativeInnovation Construction Plan of Beijing University of Chi-nese Medicine (no. 2013-XTCX-03).References[1] Editorial Committee of Chinese Pharmacopoeia, Chinese Phar-macopoeia, Medical Science and Technology Press, Beijing,China, 2015 edition, 2015.[2] Y. S. Wang, H. M. Chang, and P. P. H. But, Pharmacologyand applications of Chinese, Material Medica World Scientific,Singapore, 1987.[3] M. L. Ashour and M. Wink, \u201cGenus Bupleurum: a review ofits phytochemistry, pharmacology and modes of action,\u201d TheJournal of Pharmacy and Pharmacology, vol. 63, no. 3, pp. 305\u2013321, 2011.[4] B. P. Bermejo, M. J. A. Martinez, A. M. S. Sen et al., \u201cIn vivoand in vitro antiinflammatory activity of saikosaponins,\u201d LifeSciences, vol. 63, no. 13, pp. 1147\u20131156, 1998.[5] Y. Ma, Y. Bao, S. Wang et al., \u201cAnti-inflammation effectsand potential mechanism of saikosaponins by regulatingnicotinate and nicotinamide metabolism and arachidonic acidmetabolism,\u201d Inflammation, vol. 39, no. 4, pp. 1453\u20131461, 2016.[6] J. K. Su, Y. J. Lee, B. M. Kim et al., \u201cEffect of Bupleuri RadixExtracts on the Toxicity of 5-Fluorouracil in HepG2 HepatomaCells and Normal Human Lymphocytes,\u201d Basic & ClinicalPharmacology & Toxicology, vol. 103, no. 4, pp. 305\u2013313, 2008.[7] Y. Motoo and N. Sawabu, \u201cAntitumor effects of saikosaponins,baicalin and baicalein on human hepatoma cell lines,\u201d CancerLetters, vol. 86, no. 1, pp. 91\u201395, 1994.[8] M. S. Idris-Usman, \u201cAntinociceptive and antipyretic propertiesof the pharmaceutical herbal preparation, Radix bupleuri inrats,\u201d Journal of Medicinal Plants Research, vol. 4, no. 8, pp. 659\u2013663, 2010.[9] Q. Zhou, S.-S. Wang, G. Yang, W. Zhao, and H.-L. Li, \u201cDevel-opment and evaluation of a herbal formulation with anti-pathogenic activities and probiotics stimulatory effects,\u201d Journalof Integrative Agriculture, vol. 15, no. 5, pp. 1103\u20131111, 2016.[10] S. Wen, H. F. Xu, and H. Hao, \u201cIn vitro anti-influenza A H1N1effect of extract of Bupleuri Radix,\u201d Immunopharmacology andImmunotoxicology, vol. 33, no. 3, pp. 433\u2013437, 2011.[11] M. Yoshikawa, T. Murakami, K. Hirano, M. Inadzuki, K.Ninomiya, andH.Matsuda, \u201cScorzonerosides A, B and C, noveltriterpene oligoglycosides with hepatoprotective effect fromChinese Bupleuri radix, the roots of Bupleurum scorzoneri-folium Willd.,\u201d Tetrahedron Letters, vol. 38, no. 42, pp. 7395\u20137398, 1997.[12] Z. Wang, H. Li, H. Xu et al., \u201cBeneficial effect of Bupleurumpolysaccharides on autoimmune disease induced by Campy-lobacter jejuni in BALB/c mice,\u201d Journal of Ethnopharmacology,vol. 124, no. 3, pp. 481\u2013487, 2009.[13] H. Abe, M. Sakaguchi, H. Konishi, T. Tani, and S. Arichi,\u201cThe effects of saikosaponins on biological membranes,\u201d PlantaMedica, vol. 34, no. 6, pp. 160\u2013166, 1978.[14] S. L. Pan, \u201cBupleurum species: scientific evaluation and clinicalapplications,\u201d Tayloc and Trancis Group, FLa, USA, 2006.[15] R.-T. Tian, P.-S. Xie, and H.-P. Liu, \u201cEvaluation of traditionalChinese herbal medicine: Chaihu (Bupleuri Radix) byboth high-performance liquid chromatographic and high-performance thin-layer chromatographic fingerprint andchemometric analysis,\u201d Journal of Chromatography A, vol. 1216,no. 11, pp. 2150\u20132155, 2009.[16] H. Q. Huang, X. Zhang, Z. X. Xu, J. Su, and S. K. Yan, \u201cFastdetermination of saikosaponins in Bupleurum by rapid reso-lution liquid chromatography with evaporative light scatteringdetection,\u201d Journal of Pharmaceutical & Biomedical Analysis,vol. 49, no. 4, pp. 1048\u20131055, 2009.[17] C. Sui, J.-H. Wei, S.-L. Chen, H.-Q. Chen, L. M. Dong, and C.-M. Yang, \u201cConstruction of a full-length enriched cDNA libraryand analysis of 3111 ESTs from roots of Bupleurum ChinenseDC,\u201d Botanical Studies, vol. 51, no. 1, pp. 7\u201316, 2010.[18] H. Xie, K.-K. Huo, Z. Chao, and S.-L. Pan, \u201cIdentificationof crude drugs from Chinese medicinal plants of the genusBupleurum using ribosomal DNA ITS sequences,\u201d Planta Med-ica, vol. 75, no. 1, pp. 89\u201393, 2009.[19] L.-M. Hsu, Y.-S. Huang, S.-H. Tsay, F.-Y. Chang, and S.-D.Lee, \u201cAcute hepatitis induced by Chinese hepatoprotective herb,xiao-chai-hu-tang,\u201d Journal of the Chinese Medical Association,vol. 69, no. 2, pp. 86\u201388, 2006.[20] B. E. Van Wyk and M. Wink, Medicinal Plants of the World:An Illustrated Scientific Guide to ImportantMedicinal Plants andTheir Uses, vol. 58, Timber Press, Portland, 1st edition, 2004.[21] J. Y. Xiong, N. Zang, C. Y. Zhang et al., \u201cStudies on the anti-depression effect of Xiaoyao Powder in mic,\u201d Pharmacology andClinics of Chinese Materia Medica, vol. 23, no. 1, pp. 3\u20135, 2007.[22] Y. Zhou, Y. Ren, Z. Ma et al., \u201cIdentification and quantificationof the major volatile constituents in antidepressant active frac-tion of xiaoyaosan by gas chromatography-mass spectrometry,\u201dJournal of Ethnopharmacology, vol. 141, no. 1, pp. 187\u2013192, 2012.BioMed Research International 19[23] X. Gao, X. Zheng, Z. Li et al., \u201cMetabonomic study onchronic unpredictable mild stress and intervention effects ofXiaoyaosan in rats using gas chromatography coupled withmass spectrometry,\u201d Journal of Ethnopharmacology, vol. 137, no.1, pp. 690\u2013699, 2011.[24] Editorial Board of Flora of China, Flora of China, SciencePublishing House, Beijing, China, 1998.[25] Y. Z. Wang and Y. Y. Zhang, \u201cDetermination of species ofmedical Bupleunum,\u201dChinese Pharmaceutical Journal, no. 1, pp.3\u20138, 1994.[26] S. L. Pan, Q. S. Shun, Q. M. Bo, and X. S. Bao, The colouredatlas of the medicinal plants from genus Bupleurum in China,Shanghai Scientific and Technical Literature Press, Shangha,2002.[27] M. H. Yen, C. C. Lin, C. H. Chuang, and S. Y. Liu, \u201cEvaluationof root quality of Bupleurum species by TLC scanner andthe liver protective effects of \u201cxiao-chai-hu-tang,\u201d Journal ofEthnopharmacology, vol. 34, no. 2-3, pp. 155\u2013165, 1991.[28] X.-Q. Li, Q.-T. Gao, X.-H. Chen, and K.-S. Bi, \u201cHigh perfor-mance liquid chromatographic assay of saikosaponins fromRadix Bupleuri in China,\u201d Biological and Pharmaceutical Bul-letin, vol. 28, no. 9, pp. 1736\u20131742, 2005.[29] Q. Zhou, J. P. Hao, and K. Q. Gao, \u201cAnalysis on Saikosaponinof Sixteen Bupleurum chinense from Shanxi,\u201d Natural ProductResearch & Development, vol. 24, no. 5, pp. 644\u2013647, 2012.[30] Y.-H. Tang, Y.-Y. Zhang, H.-Y. Zhu, and C.-G. Huang, \u201cA high-performance liquid chromatographic method for saikosaponina quantification in rat plasma,\u201dBiomedical Chromatography, vol.21, no. 5, pp. 458\u2013462, 2007.[31] H. Zhang, Y. Zhao, H. Liang, L. Huang, Q. Zhang, and X. Zhi,\u201cSimultaneous HPLC-ELSD determination of saikosaponins a,c, d, f in Radix Bupleuri,\u201d Chinese Journal of PharmaceuticalAnalysis, vol. 27, no. 8, pp. 1150\u20131153, 2007.[32] R. Lucena, S. Ca\u00b4rdenas, and M. Valca\u00b4rcel, \u201cEvaporative lightscattering detection: Trends in its analytical uses,\u201d Analyticaland Bioanalytical Chemistry, vol. 388, no. 8, pp. 1663\u20131672, 2007.[33] Y. Bao, C. Li, H. Shen, and F. Nan, \u201cDetermination of saikos-aponin derivatives in Radix bupleuri and in pharmaceuticalsof the Chinese multiherb remedy Xiaochaihu-tang using liq-uid chromatographic tandem mass spectrometry,\u201d AnalyticalChemistry, vol. 76, no. 14, pp. 4208\u20134216, 2004.[34] B.-C. Liau, S.-S. Hsiao, M.-R. Lee, T.-T. Jong, and S.-T.Chiang, \u201cQuality control of Chinese medicinal preparations.LC/ESI(+)/MS/MS analyses of saikosaponins-a and -c as mark-ers of Bupleuri radix samples,\u201d Journal of Pharmaceutical andBiomedical Analysis, vol. 43, no. 3, pp. 1174\u20131178, 2007.[35] Y. Chen, J. Wang, L. Yuan, L. Zhou, X. Jia, and X. Tan, \u201cInter-action of the main components from the traditional chinesedrug pair chaihu-shaoyao based on rat intestinal absorption,\u201dMolecules, vol. 16, no. 11, pp. 9600\u20139610, 2011.[36] X. Lin, L. Xue, H. Zhang, and C. Zhu, \u201cDetermination ofsaikosaponins a, c, and d in Bupleurum Chinese DC fromdifferent areas by capillary zone electrophoresis,\u201dAnalytical andBioanalytical Chemistry, vol. 382, no. 7, pp. 1610\u20131615, 2005.[37] A. M. Fernandez-Ocana, M. V. Gomez-Rodriguez, and A.Velasco-Negueruela, \u201cIn vivo antifungal activity of the essentialoil of Bupleurum gibraltarium against Plasmopara halstedii insunflower,\u201d Journal of Agricultural& FoodChemistry, vol. 52, no.21, pp. 6414\u20136417, 2004.[38] M. A. Ocete, S. Risco, A. Zarzuelo, and J. Jimenez, \u201cPharmaco-logical activity of the essential oil of Bupleurum gibraltaricum:Anti-inflammatory activity and effects on isolated rat uteri,\u201dJournal of Ethnopharmacology, vol. 25, no. 3, pp. 305\u2013313, 1989.[39] S. H. Liu, S. S. Lu, Y. L. Su, and Y. Guo, \u201cAnalysis of volatilecompounds in Radix bupleuri injection by GC-MS-MS,\u201d Chro-matographia, vol. 74, no. 5-6, pp. 497\u2013502, 2011.[40] X. Li, Y. Jia, A. Song, X. Chen, and K. Bi, \u201cAnalysis of theessential oil fromRadix Bupleuri using capillary gas chromatog-raphy,\u201d Yakugaku Zasshi, vol. 125, no. 10, pp. 815\u2013819, 2005.[41] Y. Ushio and H. Abe, \u201cThe effects of saikosaponin onmacrophage functions and lymphocyte proliferation,\u201d PlantaMedica, vol. 57, no. 6, pp. 511\u2013514, 1991.[42] Y. Ushio and H. Abe, \u201cInactivation of measles virus and herpessimplex virus by Saikosaponin d,\u201d Planta Medica, vol. 58, no. 2,pp. 171\u2013173, 1992.[43] V. K. Wong, T. Li, B. Y. Law et al., \u201cSaikosaponin-d, a novelSERCA inhibitor, induces autophagic cell death in apoptosis-defective cells,\u201d Cell Death & Disease, vol. 4, no. 7, Article no.e720, 2012.[44] H. Otsuka, \u201cSeparation and determination of saponins ofbupleuri radix by droplet counter current chromatography(DCC),\u201d Planta Medica, vol. 33, no. 2, pp. 152\u2013159, 1978.[45] H. Matsuda, T. Murakami, K. Ninomiya, M. Inadzuki, andM. Yoshikawa, \u201cNew hepatoprotective saponins, bupleurosidesIII, VI, IX, and XIII, from Chinese Bupleuri Radix: Structure-requirements for the cytoprotective activity in primary culturedrat hepatocytes,\u201d Bioorganic and Medicinal Chemistry Letters,vol. 7, no. 17, pp. 2193\u20132198, 1997.[46] J.-K. Ding, H. Fujino, R. Kasai et al., \u201cChemical evaluation ofBupleurum species collected in Yunnan, China,\u201d Chemical andPharmaceutical Bulletin, vol. 34, no. 3, pp. 1158\u20131167, 1986.[47] D. Q. Li, J.Wu, L. Y. Liu et al., \u201cCytotoxic triterpenoid glycosides(saikosaponins) from the roots of Bupleurum chinense,\u201d Bioor-ganic & Medicinal Chemistry Letters, vol. 25, no. 18, pp. 3887\u20133892, 2015.[48] H. Seto, N. Otake, S. Q. Luo, F. G. Qian, and G. Y. Xu, \u201cStudieson chemical constituents of Bupleurum genus. Part II. Isolationof triterpenoid glycosides (saikosaponins) from Bupleurumkunmingense and their chemical structures,\u201d Agricultural &Biological Chemistry, vol. 50, no. 4, pp. 943\u2013948, 1986.[49] Y.-Y. Yang, Y.-Z. Tang, C.-L. Fan, H.-T. Luo, P.-R. Guo, and J.-X.Chen, \u201cIdentification and determination of the saikosaponins inRadix bupleuri by accelerated solvent extraction combinedwithrapid-resolution LC-MS,\u201d Journal of Separation Science, vol. 33,no. 13, pp. 1933\u20131945, 2010.[50] H. Ishii, M. Nakamura, S. Seo, K. Tori, T. Tozyo, and Y.Yoshimura, \u201cIsolation, characterization, and nuclear magneticresonance spectra of new saponins from the roots of Bupleurumfalcatum L.,\u201d Chemical and Pharmaceutical Bulletin, vol. 28, no.8, pp. 2367\u20132373, 1980.[51] Q.-X. Liu, H. Liang, Y.-Y. Zhao, B. Wang, W.-X. Yang, and Y.Yu, \u201cSaikosaponin v-1 from roots of Bupleurum chinense DC.,\u201dJournal of AsianNatural Products Research, vol. 3, no. 2, pp. 139\u2013144, 2001.[52] Y. Ogihara and M. Nose, \u201cNovel cleavage of the glycosidicbond of saponins in alcoholic alkali metal solution containinga trace of water,\u201d Journal of the Chemical Society, ChemicalCommunications, no. 18, p. 1417, 1986.[53] J. Lee, D.-H. Yang, J. H. Suh et al., \u201cSpecies discriminationof Radix Bupleuri through the simultaneous determination often saikosaponins by high performance liquid chromatographywith evaporative light scattering detection and electrospray20 BioMed Research Internationalionization mass spectrometry,\u201d Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences, vol.879, no. 32, pp. 3887\u20133895, 2011.[54] K. Shimizu, S. Amagaya, and Y. Ogihara, \u201cNew derivatives ofsaikosaponins,\u201d Chemical and Pharmaceutical Bulletin, vol. 33,no. 8, pp. 3349\u20133355, 1985.[55] R. Tundis, M. Bonesi, B. Deguin et al., \u201cCytotoxic activityand inhibitory effect on nitric oxide production of triter-pene saponins from the roots of Physospermum verticillatum(Waldst & Kit) (Apiaceae),\u201d Bioorganic and Medicinal Chem-istry, vol. 17, no. 13, pp. 4542\u20134547, 2009.[56] J. Liu, Y. Fang, L. Yang, X.Qin, G.Du, andX.Gao, \u201cA qualitative,and quantitative determination and pharmacokinetic study offour polyacetylenes from Radix Bupleuri by UPLC-PDA-MS,\u201dJournal of Pharmaceutical and Biomedical Analysis, vol. 111, no.1, pp. 257\u2013265, 2015.[57] H. Q. Huang, J. Su, X. Zhang, L. Shan, and W. D. Zhang,\u201cQualitative and quantitative determination of polyacetylenesin different Bupleurum species by high performance liquidchromatography with diode array detector and mass spectrom-etry,\u201d Journal of ChromatographyA, vol. 1218, no. 8, pp. 1131\u20131138,2011.[58] Q. C. Li, H. Liang, Y. J Bai et al., \u201cThe Chemical Constituentsfrom the Roots of Bupleurum chinense DC,\u201d Journal of ChinesePharmaceutical Sciences, vol. 7, no. 3, pp. 98-99, 1997.[59] H. Liang, Y. Y. Zhao, and R. Y. Zhang, \u201cA new chromoneglycoside from Bupleurum chinense,\u201d Chinese Chemical Letters,vol. 9, no. 1, pp. 69-70, 1998.[60] H. Liang, Y. Zhao, Y. Cui, and Q. Liu, \u201cFlavonoids from theroots of Bupleurum chinense DC,\u201d Journal of Beijing MedicalUniversity, vol. 7, no. 3, pp. 98-99, 2000.[61] L. Tan, Y. Y. Zhao, B. Wang et al., \u201cNew isoflavonoside fromBupleurum scorzonerifolium,\u201d Chinese Chemical Letters, vol. 9,no. 1, pp. 71\u201373, 1998.[62] W.-L. Chang, L.-W. Chiu, J.-H. Lai, and H.-C. Lin, \u201cImmuno-suppressive flavones and lignans from Bupleurum scorzoneri-folium,\u201d Phytochemistry, vol. 64, no. 8, pp. 1375\u20131379, 2003.[63] M. Kobayashi, T. Tawara, T. Tsuchida, and H. Mitsuhashi,\u201cStudies on the constituents of Umbelliferae plants. XVIII.Minor constituents of Bupleuri Radix: Occurrence of saiko-genins, polyhydroxysterols, a trihydroxy C18 fatty acid, a lignanand a new chromone,\u201d Chemical and Pharmaceutical Bulletin,vol. 38, no. 11, pp. 3169\u20133171, 1990.[64] Q. C. Li, H. Liang, and Y. Y. Zhao, \u201cThe chemical constituentsfrom the roots of bupleurum chinense,\u201d Journal of ChinesePharmaceutical Sciences, no. 6, pp. 165-166, 1997.[65] X. Q. Li, A. H. Song, W. Li X, and K. S. Bi, \u201cAnalysis of the fattyacid from Bupleurum chinense DC in China by GC-MS andGC-FID,\u201d Chemical & Pharmaceutical Bulletin, vol. 53, no. 12,pp. 1613\u20131617, 2006.[66] J. Y. Xie, \u201cBupleurum chinense DC polysaccharides attenuateslipopolysaccharide-induced acute lung injury in mice,\u201d Phy-tomedicine International Journal of Phytotherapy & Phytophar-macology, vol. 19, no. 2, pp. 130\u2013137, 2012.[67] J. Chun, A. Tosun, and Y. S. Kim, \u201cAnti-inflammatory effectof corymbocoumarin from Seseli gummiferum subsp. corym-bosum through suppression of NF-\ud835\udf05B signaling pathway andinduction of HO-1 expression in LPS-stimulated RAW 264.7cells,\u201d International Immunopharmacology, vol. 31, pp. 207\u2013215,2016.[68] J. Zhu, C. Luo, P. Wang, Q. He, J. Zhou, and H. Peng, \u201cSaikos-aponin A mediates the inflammatory response by inhibitingthe MAPK and NF-\ud835\udf05B pathways in LPS-stimulated RAW 264.7cells,\u201d Experimental and Therapeutic Medicine, vol. 5, no. 5, pp.1345\u20131350, 2013.[69] Y. Fu, X. Hu, Y. Cao, Z. Zhang, and N. Zhang, \u201cSaikosaponin ainhibits lipopolysaccharide-oxidative stress and inflammationin Human umbilical vein endothelial cells via preventing TLR4translocation into lipid rafts,\u201d Free Radical Biology andMedicine,no. 89, pp. 777\u2013785, 2015.[70] T. H. Lee, J. Chang, and B. M. Kim, \u201cSaikosaponin C inhibitslipopolysaccharide-induced apoptosis by suppressing caspase-3activation and subsequent degradation of focal adhesion kinasein human umbilical vein endothelial cells,\u201d Biochemical andBiophysical Research Communications, vol. 445, no. 3, pp. 615\u2013621, 2014.[71] H. Zhao, S. Li, H. Zhang et al., \u201cSaikosaponin a protects againstexperimental sepsis via inhibition of NOD2-mediated NF-\ud835\udf05Bactivation,\u201d Experimental and Therapeutic Medicine, vol. 10, no.2, pp. 823\u2013827, 2015.[72] Y. Kodama, L. Xiaochuan, C. Tsuchiya, Y. Ohizumi,M. Yoshida,and N. Nakahata, \u201cDual effect of saikogenin D: in vitroinhibition of prostaglandin E 2 production and elevation ofintracellular free Ca2+ concentration in C6 rat glioma cells,\u201dPlanta Medica, vol. 69, no. 8, pp. 765\u2013767, 2003.[73] P. Li,H.Kawachi, T.Morioka et al., \u201cSuppressive effects of Sairei-to onmonoclonal antibody 1-22-3-induced glomerulonephritis:Analysis of effective components,\u201d Pathology International, vol.47, no. 7, pp. 430\u2013435, 1997.[74] Y. Chen, X. L. Zhou, and C. R. Xue, \u201cTherapeutic effectsand mechanisms of chaihushugan decoction in experimentalchronic pancreatitis rats,\u201d Chinese Journal of Surgery of Inte-grated Traditional &WesternMedicine, no. 3, pp. 330\u2013333, 2010.[75] J. Liu, Z. Zhao, and C. R. Xue, \u201cEffect of chaihu shugan pulvison dysfunction of pancreatic exocrine secretion in patients withchronic pancreatitis,\u201d Chinese Journal of Surgery of IntegratedTraditional & Western Medicine, no. 16, pp. 275\u2013277, 2010.[76] G. B. Lenon, C. G. Li, C. C. Xue, F. C. K. Thien, and D. F. Story,\u201cInhibition of inducible nitric oxide production and iNOS pro-tein expression in lipopolysaccharide-stimulated rat aorta andRaw 264.7 macrophages by ethanol extract of a Chinese herbalmedicine formula (RCM-101) for allergic rhinitis,\u201d Journal ofEthnopharmacology, vol. 116, no. 3, pp. 547\u2013553, 2008.[77] Y.-L. Cheng, W.-L. Chang, S.-C. Lee et al., \u201cAcetone extractof Bupleurum scorzonerifolium inhibits proliferation of A549human lung cancer cells via inducing apoptosis and suppressingtelomerase activity,\u201d Life Sciences, vol. 73, no. 18, pp. 2383\u20132394,2003.[78] Y.-L. Chen, S.-Z. Lin,W.-L. Chang, Y.-L. Cheng, andH.-J. Harn,\u201cRequirement for ERK activation in acetone extract identifiedfrom Bupleurrum scorzonerifolium induced A549 tumor cellapoptosis and keratin 8 phosphorylation,\u201d Life Sciences, vol. 76,no. 21, pp. 2409\u20132420, 2005.[79] Y.-L. Cheng, S.-C. Lee, S.-Z. Lin et al., \u201cAnti-proliferative activityof Bupleurum scrozonerifolium in A549 human lung cancercells in vitro and in vivo,\u201dCancer Letters, vol. 222, no. 2, pp. 183\u2013193, 2005.[80] Y.-L. Hsu, P.-L. Kuo, T.-C. Weng, M.-H. Yen, L.-C. Chiang, andC.-C. Lin, \u201cThe antiproliferative activity of saponin-enrichedfraction from Bupleurum kaoi is through Fas-dependent apop-totic pathway in human non-small cell lung cancer A549 cells,\u201dBiological and Pharmaceutical Bulletin, vol. 27, no. 7, pp. 1112\u20131115, 2004.BioMed Research International 21[81] L.-C. Chiang, L. T. Ng, L.-T. Liu, D.-E. Shieh, and C.-C. Lin,\u201cCytotoxicity and anti-hepatitis B virus activities of saikos-aponins from Bupleurum species,\u201d Planta Medica, vol. 69, no.8, pp. 705\u2013709, 2003.[82] H. L. Hou, S. X. He, Z. F. Zhu et al., \u201c\u201cThe role of saikosaponind in regulating HIF-1\ud835\udefc/COX-2 signal transduction pathway inhuman hepatocellular carcinoma cells,\u201d Journal of Xian JiaotongUniversity, vol. 32, pp. 80\u201384, 2011.[83] S. Willimott, J. Barker, L. A. Jones, and E. I. Opara, \u201cAn in vitrobased investigation of the cytotoxic effect ofwater extracts of theChinese herbal remedy LD on cancer cells,\u201d Chemistry CentralJournal, vol. 3, no. 1, pp. 1\u201316, 2009.[84] T. Kuroki, \u201cProspective study of chemoprevention of hepatocel-lular carcinoma with sho-saiko-to (TJ-9),\u201dCancer, vol. 76, no. 5,pp. 743\u2013749, 1995.[85] H. Y. Zhao, \u201cClinical observation of the treatment of primaryliver cancer by using xiao-chai-hu decoction,\u201d Journal of Tradi-tional Chinese Medicine, no. 18, p. 32, 1995.[86] K. Haranaka, N. Satomi, A. Sakurai, R. Haranaka, N. Okada,and M. Kobayashi, \u201cAntitumor activities and tumor necrosisfactor producibility of traditional Chinese medicines and crudedrugs,\u201d Cancer Immunology Immunotherapy, vol. 20, no. 1, pp.1\u20135, 1985.[87] J.-S. Chang, K.-C. Wang, H.-W. Liu, M.-C. Chen, L.-C. Chiang,and C.-C. Lin, \u201cSho-saiko-to (Xiao-Chai-Hu-Tang) and crudesaikosaponins inhibit Hepatitis B virus in a stable HBV-producing cell line,\u201d American Journal of Chinese Medicine, vol.35, no. 2, pp. 341\u2013351, 2007.[88] F. Yin, R. Pan, R. Chen, and L. Hu, \u201cSaikosaponins fromBupleurum chinense and inhibition of HBV DNA replicationactivity,\u201dNatural Product Communications, vol. 3, no. 2, pp. 155\u2013157, 2008.[89] P. W. Cheng, L. T. Ng, L. C. Chiang, and C. C. Lin, \u201cAntiviraleffects of saikosaponins on human coronavirus 229E in vitro,\u201dClinical & Experimental Pharmacology & Physiology, vol. 33, no.7, pp. 612\u2013616, 2006.[90] G. T. Jin, L. Bo, and S. R.Wang, \u201cExperimental study onmaterialbasis, efficacy and mechanism of antipyretic effect of BupleuriRadix,\u201d Journal of Chengdu University of Traditional ChineseMedicine, no. 36, pp. 28\u201330, 2013.[91] S.-L. Cao, E. Chen, Q.-Z. Zhang, and X.-G. Jiang, \u201cA novelnasal delivery system of a Chinese traditional medicine, Radixbupleuri, based on the concept of ion-activated in situ gel,\u201dArchives of Pharmacal Research, vol. 30, no. 8, pp. 1014\u20131019,2007.[92] Y. Xie,W. Lu, S. Cao, X. Jiang,M.Yin, andW.Tang, \u201cPreparationof bupleurum nasal spray and evaluation on its safety andefficacy,\u201d Chemical and Pharmaceutical Bulletin, vol. 54, no. 1,pp. 48\u201353, 2006.[93] Y. Li, C. Xu, Q. Zhang, J. Y. Liu, and R. X. Tan, \u201cIn vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines usedto treat ulcer diseases,\u201d Journal of Ethnopharmacology, vol. 98,no. 3, pp. 329\u2013333, 2005.[94] Y. Kumazawa, T. Kawakita, H. Takimoto, and K. Nomoto,\u201cProtective effect of saikosaponin a, saikosaponin d and saiko-genin D against Pseudomonas aeruginosa infection in mice,\u201dInternational Journal of Immunopharmacology, vol. 12, no. 5, pp.531\u2013537, 1990.[95] X.M. Du, H. Xie, and Y. Kang, \u201cThe Pharmacological activity ofchinese \u201cchaihu\u201d-the root of bupleurum species,\u201d Sci Eval ClinAppl, no. 10, pp. 135\u2013149, 2006.[96] Z.-Y. Li, H.-M. Sun, J. Xing, X.-M. Qin, and G.-H. Du,\u201cChemical and biological comparison of raw and vinegar-bakedRadix Bupleuri,\u201d Journal of Ethnopharmacology, vol. 165, pp. 20\u201328, 2015.[97] H. Abe, M. Sakaguchi, M. Yamada, S. Arichi, and S. Odashima,\u201cPharmacological actions of saikosaponins isolated fromBupleurum falcatum. I. Effects of saikosaponings on liverfunction,\u201d Planta Medica, vol. 40, no. 4, pp. 366\u2013372, 1980.[98] H. Matsuda, T. Murakami, K. Ninomiya, M. Inadzuki, andM. Yoshikawa, \u201cNew hepatoprotective saponins, bupleurosidesIII, VI, IX, and XIII, from Chinese Bupleuri Radix: Structure-requirements for the cytoprotective activity in primary culturedrat hepatocytes,\u201d Bioorganic & Medicinal Chemistry Letters, vol.28, no. 52, pp. 2193\u20132198, 1997.[99] X. H. Han, X. D. Gai, Y. J. Xue, and M. Chen, \u201cEffects ofthe extracts from Bupleurum Chinese DC on intracelluar freecalcium concentration and vincristine accumulation in humanhepatoma BEL-7402 cells,\u201d Tumor, no. 26, pp. 314\u2013317, 2006.[100] H. Abe, M. Sakaguchi, S. Odashima, and S. Arichi, \u201cProtectiveeffect of saikosaponin-d isolated from Bupleurum falcatum L.onCCl4-induced liver injury in the rat,\u201dNaunyn-Schmiedeberg\u2019sArchives of Pharmacology, vol. 320, no. 3, pp. 266\u2013271, 1982.[101] J. Fan, X. Li, P. Li et al., \u201cSaikosaponin-d attenuates thedevelopment of liver fibrosis by preventing hepatocyte injury,\u201dBiochemistry & Cell Biology, vol. 85, no. 2, pp. 189\u2013195, 2007.[102] M. Yamakage, J.-I. Hattori, J.-I. Satoh, and A. Namiki, \u201cEffectsof the Chinese herbal medicines Bupleuri radix, Ginseng radix,and Zingiberis rhizoma on lymphatic vessel activity in rats,\u201dAmerican Journal of Chinese Medicine, vol. 34, no. 6, pp. 1063\u20131068, 2006.[103] Y. Kumazawa, H. Takimoto, C. Nishimura, T. Kawakita, andK. Nomoto, \u201cActivation of murine peritoneal macrophages bysaikosaponin a, saikosaponin d and saikogenin d,\u201d InternationalJournal of Immunopharmacology, vol. 11, no. 1, pp. 21\u201328, 1989.[104] M. Kato, M.-Y. Pu, K.-I. Isobe, T. Hattori, N. Yanagita, and I.Nakashima, \u201cCell type-oriented differential modulatory actionsof saikosaponin-d on growth responses and DNA fragmen-tation of lymphocytes triggered by receptor-mediated andreceptor-bypassed pathways,\u201d Immunopharmacology, vol. 29,no. 3, pp. 207\u2013213, 1995.[105] M. Kato, M.-Y. Pu, K.-I. Isobe et al., \u201cCharacterization ofthe immunoregulatory action of saikosaponin-d,\u201d CellularImmunology, vol. 159, no. 1, pp. 15\u201325, 1994.[106] V. K. W. Wong, H. Zhou, S. S. F. Cheung, T. Li, and L. Liu,\u201cMechanistic study of saikosaponin-d (Ssd) on suppression ofmurine T lymphocyte activation,\u201d Journal of Cellular Biochem-istry, vol. 107, no. 2, pp. 303\u2013315, 2009.[107] H. Yi, B. Long, X. Ye, L. Zhang, X. Liu, and C. Zhang,\u201cAutophagy: A potential target for thyroid cancer therapy(Review),\u201d Molecular and Clinical Oncology, vol. 2, no. 5, pp.661\u2013665, 2014.[108] N. Mizushima, \u201cAutophagy: process and function,\u201d Genes &Development, vol. 21, no. 22, pp. 2861\u20132873, 2007.[109] D. C. Rubinsztein, P. Codogno, and B. Levine, \u201cAutophagymod-ulation as a potential therapeutic target for diverse diseases,\u201dNature Reviews Drug Discovery, vol. 11, no. 9, pp. 709\u2013730, 2012.[110] Z. J. Yang, C. E. Chee, S. Huang, and F. A. Sinicrope, \u201cThe roleof autophagy in cancer: therapeutic implications,\u201d MolecularCancer Therapeutics, vol. 10, no. 9, pp. 1533\u20131541, 2011.[111] E.-L. Eskelinen, \u201cThe dual role of autophagy in cancer,\u201d CurrentOpinion in Pharmacology, vol. 11, no. 4, pp. 294\u2013300, 2011.22 BioMed Research International[112] O. Yamaguchi and K. Otsu, \u201cRole of autophagy in aging,\u201dJournal of Cardiovascular Pharmacology, vol. 60, no. 3, pp. 242\u2013247, 2012.[113] B. Y. Law, J. F. Mo, and V. K. Wong, \u201cAutophagic effects ofChaihu (dried roots of Bupleurum Chinense DC or BupleurumscorzoneraefoliumWILD),\u201dChineseMedicine, vol. 9, no. 1, article21, 2014.[114] Y. Cheng, Y. Huang, Y. Tian, L. Xu, G. Q. Liu, and Z. J. Zahng,\u201cAssessment of the effects of Radix Bupleuri and vinegar-baked Radix Bupleuri on cytochrome 450 activity by a six-drugcocktail approach,\u201dChinese Journal of Natural Medicines, vol. 11,no. 3, pp. 302\u2013308, 2013.[115] X. Chen, T. Yu, Z. Chen, R. Zhao, and S. Mao, \u201cEffect ofsaikosaponins and extracts of vinegar-baked Bupleuri Radix onthe activity of \ud835\udefd-glucuronidase,\u201d Xenobiotica, vol. 44, no. 9, pp.785\u2013791, 2014.[116] M. Ye, Y.-F. Bi, L. Ding, W.-W. Zhu, and W. Gao, \u201cSaikosaponina functions as anti-epileptic effect in pentylenetetrazol inducedrats through inhibiting mTOR signaling pathway,\u201d Biomedicineand Pharmacotherapy, vol. 81, pp. 281\u2013287, 2016.[117] D. He, H. Wang, L. Xu et al., \u201cSaikosaponin-a AttenuatesOxidized LDL Uptake and Prompts Cholesterol Efflux in THP-1 Cells,\u201d Journal of Cardiovascular Pharmacology, vol. 67, no. 6,pp. 510\u2013518, 2016.[118] K.-G. Shyu, S.-C. Tsai, B.-W. Wang, Y.-C. Liu, and C.-C. Lee,\u201cSaikosaponin C induces endothelial cells growth, migrationand capillary tube formation,\u201d Life Sciences, vol. 76, no. 7, pp.813\u2013826, 2004.[119] T. H. Lee, S. H. Park,M.-H. You, J.-H. Lim, S.-H.Min, and B.M.Kim, \u201cA potential therapeutic effect of saikosaponin C as a noveldual-target anti-Alzheimer agent,\u201d Journal of Neurochemistry,vol. 136, no. 6, pp. 1232\u20131245, 2016.[120] S. Zhu, F. Ling, Q. Zhang et al., \u201cAnthelmintic activity ofsaikosaponins a and d from radix bupleuri againstDactylogyrusspp. infecting goldfish,\u201d Diseases of Aquatic Organisms, vol. 111,no. 2, pp. 177\u2013182, 2014.[121] S. C. Cui, Q. Z. Cao, and C. X. Su, \u201cAnalysis of 50 cases of drug-induced liver disease,\u201d Journal of Capital Medicine University,vol. 20, pp. 296-297, 1999.[122] D. C. H. Teo, P. S. L. Ng, S. H. Tan et al., \u201cDrug-inducedliver injury associated with Complementary and AlternativeMedicine: A review of adverse event reports in an Asiancommunity from 2009 to 2014,\u201d BMC Complementary andAlternative Medicine, vol. 16, no. 1, pp. 1\u201311, 2016.[123] S. Itoh, K. Marutani, T. Nishijima, S. Matsuo, and M. Itabashi,\u201cLiver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang),\u201dDigestive Diseases and Sciences, vol. 40, no. 8, pp.1845\u20131848, 1995.[124] C.-H. Lee, J.-D. Wang, and P.-C. Chen, \u201cRisk of Liver InjuryAssociated with Chinese Herbal Products Containing Radixbupleuri in 639, 779 Patients with Hepatitis B Virus Infection,\u201dPLoS ONE, vol. 6, no. 1, Article ID e16064, 2011.[125] R. Sun, L.Wang,Q. Yang,W.Huang, and L. L. Lv, \u201cAcute toxicityof volatile oil from Bupleurum chinense in rats and mice,\u201dChinese Journal of Experimental Traditional Medical Formulae,vol. 16, pp. 154\u2013156, 2010.[126] W. Huang, R. Sun, and Z. Zhang, \u201c\u201cDose-time-toxicity\u201d rela-tionship study onhepatotoxicity caused bymultiple dose of totalBupleurum saponin crude extracts to rats,\u201d China Journal ofChinese Materia Medica, vol. 35, no. 35, pp. 3344\u20133347, 2010.[127] L. Xu, R. Song, J.-X. Tian, Y. Tian, G.-Q. Liu, and Z.-J.Zhang, \u201cAnalysis of saikosaponins in rat plasma by anionicadducts-based liquid chromatography tandem mass spectrom-etry method,\u201d Biomedical Chromatography, vol. 26, no. 7, pp.808\u2013815, 2012.[128] L. Lin, B. Ni, H. Lin et al., \u201cTraditional usages, botany,phytochemistry, pharmacology and toxicology of Polygonummultiflorum Thunb.: a review,\u201d Journal of Ethnopharmacology,vol. 159, pp. 158\u2013183, 2015.Submit your manuscripts athttps://www.hindawi.comPainResearch and TreatmentHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.comVolume 2014ToxinsJournal ofVaccinesJournal ofHindawi Publishing Corporation http://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014AntibioticsInternational Journal ofToxicologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014StrokeResearch and TreatmentHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Drug DeliveryJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Advances in Pharmacological SciencesTropical MedicineJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Medicinal ChemistryInternational Journal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014AddictionJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014BioMed Research InternationalEmergency Medicine InternationalHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014 Autoimmune DiseasesHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014 Anesthesiology Research and PracticeScientificaHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Journal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014PharmaceuticsHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014MEDIATORSINFLAMMATIONof"}